Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 142374-19-4 | MDL No. : | MFCD03425258 |
Formula : | C12H21NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PSRHRFNKESVOEL-UHFFFAOYSA-N |
M.W : | 227.30 | Pubchem ID : | 10353694 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.83 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 66.41 |
TPSA : | 46.61 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.77 cm/s |
Log Po/w (iLOGP) : | 2.66 |
Log Po/w (XLOGP3) : | 1.29 |
Log Po/w (WLOGP) : | 1.84 |
Log Po/w (MLOGP) : | 1.33 |
Log Po/w (SILICOS-IT) : | 1.62 |
Consensus Log Po/w : | 1.75 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.73 |
Solubility : | 4.21 mg/ml ; 0.0185 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.87 |
Solubility : | 3.08 mg/ml ; 0.0135 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.64 |
Solubility : | 5.27 mg/ml ; 0.0232 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.08 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With oxalyl dichloride In dichloromethane; dimethyl sulfoxide at -60℃; for 1.5h; | b b.Add oxalyl chloride (50 g, 0.394 mol)In dichloromethane (1L),Add slowly at -60 Dimethyl sulfoxide (45.9 mL, 0.6575 mol),Stir for 30 minutes.Compound 2 (120 g, 100%) at -60 ° CDissolved in dichloromethane (500mL),It was slowly poured into the above reaction.After adding, mixThe mixture was stirred at -60 ° C for 1 hour.TLC (petroleum ether / ethyl acetate volume ratio = 2/1) showed the end of the reaction.Add at minus 60 Triethylamine (183mL, 1.315mol),Stir for 30 minutes.The reaction solution was warmed to room temperature,Then add water (1L), separate the organic phase,The aqueous phase was extracted with ethyl acetate (500 mL x 3).The combined organic phases were washed twice with ammonium chloride (500 mL),Add sodium sulfate to dry,A pale yellow oily compound 3 (60 g) was obtained in a yield of 100%. |
96% | With oxalyl dichloride; dimethyl sulfoxide; triethylamine at -60 - 20℃; | |
92% | With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; trichloroisocyanuric acid In dichloromethane at 0℃; for 1h; | 30.1 Example 30: Synthesis of (2S,5R)-7-oxo-2-(5-(piperidin-4-ylmethyl)isoxazol-3-yl)-l ,6- diazabicyclo[3.2.1 loctan-6-yl hydrogen sulfate (Compound 627) Example 30: Synthesis of (2S,5R)-7-oxo-2-(5-(piperidin-4-ylmethyl)isoxazol-3-yl)-l ,6- diazabicyclo[3.2.1 loctan-6-yl hydrogen sulfate (Compound 627) Synthetic scheme: Characterization: (2S,5R)-7-oxo-2-(5-(piperidin-4-ylmethyl)isoxazol-3-yl)-l,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate (627, 31 mg) was obtained as a white solid after prep-HPLC purification using ammonium formate buffer. ESI-MS (EI+, m/z): 387.0. |
90% | With oxalyl dichloride; dimethyl sulfoxide; triethylamine In dichloromethane at -60 - 20℃; | |
89% | Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 1h; Stage #2: With triethylamine In dichloromethane at -78 - 20℃; | |
85% | With pyridinium chlorochromate In dichloromethane at 20℃; for 6h; | |
85% | With sodium hypochlorite; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; Sodium hydrogenocarbonate; sodium chloride; potassium bromide In dichloromethane; water monomer at 0℃; for 1.16667h; | |
85% | With sodium chlorine monoxide; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; Sodium hydrogenocarbonate; sodium chloride; potassium bromide In dichloromethane; water monomer at 0℃; for 1.16667h; | |
81% | With pyridine-SO3 complex; triethylamine In dimethyl sulfoxide at 10 - 20℃; for 1.5h; | |
80% | With sulphur trioxide pyridine complex; dimethyl sulfoxide; triethylamine | |
71% | Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 0.25h; Stage #2: With triethylamine In dichloromethane at -78 - 0℃; for 0.5h; | |
66% | With pyridinium chlorochromate In dichloromethane at 0 - 20℃; for 2h; | 18-1 tert-butyl 4- (2-oxoethyl) piperidine-1-carboxylate To a solution of tert-butyl 4- (2-hydroxyethyl) piperidine-1-carboxylate (6.87 g, 30 mmol) in DCM (100 mL) was added PCC (9.72 g, 45 mmol) at 0. The reaction mixture was allowed to stir at rt for 2h and then concentrated under reduced pressure to give crude product which was purified by column chromatography (silica gel: 300-400 mesh, PE/EtOAc 20/1 to 5/1) to afford tert-butyl 4- (2-oxoethyl) piperidine-1-carboxylate (4.5 g, 66) . LRMS m/z (M-100) 128.1 found, 128.1 required. |
60% | With Dess-Martin periodane In dichloromethane at 0 - 20℃; for 5h; | Step 2: tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (LXXII) To a stirred solution of tert-butyl 4-(2-hydroxyethyl)piperidine-1-carboxylate (LXXI, 1.5 g, 6.55 mmol) in dry dichloromethane (40 mL) was added Dess-Martin periodinane (3.3 g, 7.86 mmol) at 0 °Cand the resulting mixture was stirred at room temperature for 5 h. The reaction mixture was quenched with 10 % sodium thiosulphate solution (20 mL) and saturated sodium bicarbonate solution (20 mL) and then extracted with dichloromethane (2 x 50 mL).The organic portion was washed with saturated sodium bicarbonate solution, water, brine, dried over sodium sulphate and concentrated under reduced pressure to afford the product as yellow semi-solid (LXXII, 0.9 g, 60 %). |
40% | With Dess-Martin periodane In dichloromethane at 20℃; for 2h; | |
With oxalyl dichloride; dimethyl sulfoxide; triethylamine 1.) CH2Cl2, -78 deg C, 20 min, 2.) CH2Cl2, from -78 deg C to RT, 1.5 h; Multistep reaction; | ||
With oxalyl dichloride; dimethyl sulfoxide; N-ethyl-N,N-diisopropylamine In dichloromethane | ||
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; [bis(acetoxy)iodo]benzene In dichloromethane for 3h; | tert-Butyl 4-(formylmethyl)piperidine-1-carboxylate: To a flask containing tert-butyl 4-(2 hydroxyethyl)piperidine-1-carboxylate (4.4 g, 19.2 mmol) in CH2Cl2 (20 mL) was added TEMPO (300 mg, 1.92 mmol) followed by iodobenzene diacetate (6.8 g, 21.1 mmol). The reaction was stirred 3 hours and then diluted with CH2Cl2 (100 mL). Saturated aqueous solution of Na2S2O3 (100 mL) was added and extracted with CH2Cl2 (3×50 mL). The combined organics were washed with saturated aqueous NaHCO3 (150 mL) and brine (150 mL), dried over Na2SO4, and concentrated in vacuo. The resulting residue was purified by silica gel chromatography (40-70% Et2O/pentanes) to provide the title compound, which was identical to the reported literature compound (see Sato et al. (2001) Heterocycle 54: 747). 13C NMR (75 MHz, CDCl3) 201.5, 154.7, 79.4, 50.3, 43.7, 31.9, 30.6, 28.4. | |
With pyridinium chlorochromate In dichloromethane; ethyl acetate | 268.B B. B. 1-(tert-Butoxycarbonyl)piperidine-4-acetaldehyde A solution of 1-(tert-butoxycarbonyl)piperidine-4-ethanol (5.0 g, 22 mmol) in methylene chloride (100 mL) was treated with pyridinium chlorochromate (5.2 g, 24 mmol), and diatomaceous earth (5 g). After 3 days, the mixture was filtered through diatomaceous earth, concentrated, and the residue purified by column chromatography (SiO2: 20 to 30% EtOAc:hexanes) affording 4.0 g (81%) of the title compound. 1NMR; IS-MS, m/e 228 (m+1). | |
With pyridine-SO3 complex; triethylamine In dichloromethane; dimethyl sulfoxide for 2h; | 8.A Example 8 fert-Butyl 4-[2-hydroxy-2-(4-oxo-2-phenyl-455-dihydro-2i-7-pyrazolo[354-c]quinolin-l- yl)ethyl]piperidine- 1 -carboxylatePart A To a mixture of tert-hvXy 4-(2-hydroxyethyl)ρiperidine-l -carboxylate (3.4 g, 15 mmol) and dichloromethane (18 mL) at 0 °C was added triethyl amine (10 mL), dimethyl sulfoxide (18 mL), and sulfur trioxide pyridine (5.9 g, 37 mmol). The reaction was stirred 2 hours before diluting with ethyl acetate and saturated aqueous ammonium chloride. The layers were separated and the aqueous layer was extracted with additional ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated to 3.3 g of tert-hvXy 4-(2-oxoethyl)piperidine-l -carboxylate as a colorless oil. | |
Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With trichloroisocyanuric acid In dichloromethane at 0 - 20℃; for 1h; Stage #2: With anhydrous sodium carbonate In dichloromethane; water monomer | b; 20.C Trichloroisocyanuric acid (2.66 g, 11.46 mmol) is added to a solution of the alcohol (2.39 g, 10.42 mmol) in DCM, and the solution is stirred and maintained at 0° C., followed by addition of a catalytic amount of TEMPO. After the addition, the mixture is warmed to room temperature and stirred for an hour and then filtered on Celite. The organic phase is washed with saturated aqueous Na2CO3, followed by 1N HCl and brine. The organic layer is dried (MgSO4), and the solvent is evaporated to yield 20-C. 1H-NMR (CDCl3, 400 MHz) δ 9.72 (1H, s), 4.07-4.01 (2H, m), 2.70-2.57 (2H, m), 2.35-2.31 (2H, m), 2.05-1.94 (1H, m), 1.64-1.46 (2H, m), 1.39 (9H, s), 1.30-1.02 (2H, m). | |
With trichloroisocyanuric acid In dichloromethane at 0 - 20℃; for 1h; | 1.b 1-C: Trichloroisocyanuric acid (2.66 g, 11.46 mmol) is added to a solution of the alcohol 1-B (2.39 g, 10.42 mmol) in DCM, and the solution is stirred and maintained at 0 C., followed by addition of a catalytic amount of TEMPO. After the addition, the mixture is warmed to room temperature and stirred for an hour and then filtered on Celite. The organic phase is washed with saturated aqueous Na2CO3, followed by 1N HCl and brine. The organic layer is dried (MgSO4) and the solvent is evaporated to give 1-C. 1H NMR (CDCl3, 400 MHz) ? 9.72 (1H, s), 4.07-4.01 (2H, m), 2.70-2.57 (2H, m), 2.35-2.31 (2H, m), 2.05-1.94 (1H, m), 1.64-1.46 (2H, m), 1.39 (9H, s), 1.30-1.02 (2H, m). | |
With oxalyl dichloride; triethylamine In dichloromethane; dimethyl sulfoxide at -78 - 20℃; for 5h; | ||
With trichloroisocyanuric acid In dichloromethane at 0 - 20℃; for 1h; | b Trichloroisocyanuric acid (2.66 g, 11.46 mmol) is added to a solution of the alcohol (2.39 g, 10.42 mmol) in DCM, and the solution is stirred and maintained at 0 0C, followed by addition of a catalytic amount of TEMPO. After the addition, the mixture is warmed to room temperature and stirred for an hour and then filtered on Celite. The organic phase is washed with saturated aqueous Na2Cθ3, followed by IN HCL and brine. The organic layer is dried (MgSO4) and the solvent is evaporated to give 4-C. 1H NMR (CDCI3, 400 MHz) δ 9.72 (IH, s), 4.07-4.01 (2H, m), 2.70-2.57 (2H, m), 2.35-2.31 (2H, m), 2.05- 1.94 (IH, m), 1.64-1.46 (2H, m), 1.39 (9H, s), 1.30-1.02 (2H, m). | |
With trichloroisocyanuric acid In dichloromethane at 0 - 20℃; for 1h; | b Trichloroisocyanuric acid (2.66g, 11.46 mmol) is added to a solution of the alcohol (2.39g, 10.42 mmol) in CH2Cl2, and the solution is stirred and maintained at 0 0C, followed by addition of a catalytic amount of TEMPO. After the addition, the mixture is warmed to room temperature and stirred for an hour and then filtered on Celite. The organic phase is washed with saturated aqueous Na2CO3, followed by IN HCl and brine. The organic layer is dried (MgSO4) and the solvent is evaporated to give compound 8-C. 1H NMR (CDCl3, 400 MHz) δ 9.72 (IH, s), 4.07-4.01 (2H, m), 2.70-2.57 (2H, m), 2.35-2.31 (2H, m), 2.05-1.94 (IH, m), 1.64-1.46 (2H, m), 1.39 (9H, s), 1.30-1.02 (2H, m). | |
Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 0.666667h; Stage #2: With triethylamine In dichloromethane at -78 - 30℃; for 5h; | 1.1 Dimethyl sulfoxide (7.43 mL, 0.105 mol) was added to oxalyl chloride (5.53 mL, 0.0654 mol) in methylene chloride (244.2 mL) at -78 0C. After 10 min, tert-butyl 4-(2-hydroxyethyl)piperidine- 1 - carboxylate (10.0 g, 0.0436 mol) in methylene chloride (488.4 mL) was added and the resultant mixture was stirred at -78 0C for 30 min. Triethylamine (30.4 mL, 0.218 mol) was then added and the mixture was stirred for 5 h with the temperature allowed to gradually warm up to room temperature. After being quenched with water, the mixture was extracted with methylene chloride. The organic layers were combined, washed with brine, dried over MgSO/t, evaporated to dryness and used directly in next step. LCMS (M+Na) 250.0. | |
With 2,2,6,6-tetramethyl-1-piperidinyloxy free radical; [bis(acetoxy)iodo]benzene In dichloromethane at 20℃; for 2h; | ||
With sulphur trioxide pyridine complex; triethylamine In dimethyl sulfoxide at 20℃; for 0.5h; | 21 Reference Example 21 8.60 ml of di-tert-butyl dicarbonate was added to a solution of 5.00 g of 2-piperidin-4-ylethanol in 50 ml of tetrahydrofuran, followed by stirring at ambient temperature for 30 minutes. The reaction mixture was concentrated under reduced pressure and the resulting residue was purified by silica gel column chromatography (hexane-ethyl acetate) to give 8.80 g of an oil. The oil was dissolved in 60 ml of dimethylsulfoxide, and the resulting solution was added 20.5 ml of triethylamine and 12.2 g of sulfur trioxide-pyridine complex, followed by stirring at ambient temperature for 30 minutes. The reaction mixture was poured into saturated aqueous sodium bicarbonate, followed by extraction with ethyl acetate. The organic layer was washed with saturated aqueous sodium chloride and then dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated and the residue was purified by silica gel column chromatography (hexane-ethyl acetate) to give 6.40 g of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate. _ | |
With Dess-Martin periodane In dichloromethane at 0 - 20℃; for 2h; | 5.1 70.9 g (167 mmol) of 1,1,1-tris(acetyloxy)-1,1-dihydro-1,2-benziodoxol-3-(1H)-one (Dess-Martin reagent) are added portionwise to a solution, cooled to 0° C., of 30.4 g (132 mmol) of tert-butyl 4-(2-hydroxyethyl)piperidine-1-carboxylate in 150 ml of dichloromethane. The mixture is stirred at ambient temperature for 2 hours, then 150 ml of a 10% aqueous sodium thiosulphate (Na2S2O3) solution are added and stifling is continued for an additional 30 minutes. The organic phase is separated by settling, washed with a saturated aqueous sodium carbonate solution, dried over sodium sulphate and evaporated to dryness to produce 30.1 g (132 mmol) of product in the form of a colourless oil used as is in the following stage. | |
Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 1.5h; Stage #2: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester In dichloromethane at -78℃; for 1.33333h; Stage #3: With triethylamine more than 3 stages; | 14 Example 14; [1- [1-OXO-3- (5,] 6,7, [8-TETRAHYDRO-1,] 8-naphthyridin-2-yl) [PROPYL]-D-PHENYL-4-] piperidinebutanoic acid (Cpd 13) Di-tert-butyl dicarbonate (41.25g, 189 mmol) was added in one portion to a solution of 4- (2-hydroxyethyl) piperidine Compound 14a (24.42g, 189 mmol) in DMF (200 mL) at [0 °C.] After 1 hour, the cooling bath was removed and the reaction mixture was allowed to stir for 20 h at RT. The reaction mixture was treated with Et2O (200 [ML)] and [H20] (500 mL). The organic layer was separated, washed with sat NH4C1 (200 mL) and brine (200 mL) and dried [MGS04).] After filtration and evaporation, Compound 14b was obtained as a transparent oil and used as such without further purification. A solution of DMSO (14g, 179 mmol) in DCM (80 mL) was added dropwise over a period of 1.5 h to a 2M solution of oxalyl chloride (62.8mL, 125.6 mmol) in dry DCM (200 mL) [AT-78 °C,] such that the temperature did not [EXCEED-60 °C.] A solution of Compound 14a in DCM (30 mL) was added dropwise at-78°C over a 50 min period. After stirring 30 min [AT-78 °C,] the cooling bath was removed and the temperature of the reaction mixture was allowed to rise to-30 °C over a 30 min period. TEA (25.41 g, 251 mmol) was added and the reaction mixture was allowed to stir for lh at rt. The solid precipitate that had formed was removed by filtration and the filtrate was washed with 0.3N [HC1] (2 x [100] mL) and brine (200 mL). The organic phase was dried [(NA2SO4),] evaporated and the residue was purified via flash column chromatography (eluent gradient : hexane/EtOAc 100/0 to 70/30) to yield Compound 14c. A 1M solution [OF LIHMDS] (73 mL, 73 mmol) was added via syringe to a solution of trimethyl phosphonoacetate (13.29g, 73 mmol) in THF (200 mL) at-78°C under argon. The reaction mixture was then stirred for 20 min at-78°C and a solution of Compound 14c (8.3g, 36.5 mmol) in THF (50 mL) was added over a 30 min period. After stirring for 15 min [AT-78 °C,] the cooling bath was removed and the reaction mixture was heated to reflux for 2. The reaction mixture was allowed to cool to room temperature and a saturated [NH4CL] solution (40 mL) was added. [ET20] (200 mL) was added, the organic layer was separated and washed with brine (140 mL) and dried [(NA2S04).] After filtration and evaporation, the residue was purified via flash column chromatography (eluent gradient : hexane/EtOAc: 100/0 to 85/15), yielding a mixture of [E-AND] Z- isomers of Compound 14d. Compound 14d, phenyl boronic acid [(1.] [55G,] 12.32 mmol), [RhCl (Cod) ] 2 [(0.] [LU ; 0.] 227 mmol) and Cod (0.557g, 5.15 mmol) were combined in [H20] [(15ML)] and heated to 100 [°C] for 3 h under a nitrogen atmosphere. Phenylboronic acid [(L.] [OG,] 8. 2 mmol) was added again and the reaction mixture was heated to [100 °C] for another 6 h. The reaction mixture was allowed to cool to rt, Et20 (100 mL) was added and the organic layer was separated. The aqueous layer was washed with [ET20] (2 x 100 mL) and the combined organic layers were dried [(NA2SO4),] filtered and evaporated. The residue was purified via flash column chromatography, yielding Compound 14e. TFA (6 mL) was added to a solution of Compound 14e (1.48 g, 4.09 mmol) in DCM (14 mL). The mixture was stirred at rt for 20 min, concentrated under vacuum and purified via RP-HPLC to yield Compound 14f as a trifluoroacetate salt. HOBt (0.333 g, 2.46 mmol), EDC (0.47 g, 2.46 mmol) and NMM (0.68 g, 5.28 mmol) were added to a solution of Compound 8a [(0. 64] g, 2.64 mmol) in DMF (30 mL) under argon. The mixture was stirred at rt for 1 h, then a solution of Compound 14f (0.66 g, 1.76 mmol) and NMM (0. [68] g, 5.28 mmol) in DMF (10 mL) was added. The resulting mixture was stirred overnight at rt. Water (2 mL) was added, followed by DCM (20 mL). The organic layer was separated, dried [(NA2SO4)] and concentrated. The resulting crude Compound 14g was used as such in the next reaction. To a solution of Compound 14g in dioxane (2 mL) and [H20] [(1] mL) was added [NAOH] (0.78g, 19. 5 mmol). The mixture was stirred at rt for 5 h and neutralized with 2N HCI. After the solvent was evaporated, the residue was purified by RP-HPLC to give Compound 13 after lyophilization | |
With Dess-Martin periodane In dichloromethane at 20℃; for 1.5h; | 22.1 To a solution of ter£-butyl 4-(2-hydroxyethyl)piperidine-l-carboxylate (0.6 g, 2.6 mmol) in dichloromethane (30 mL) was added Dess-Martin-periodinane (1.2 g, 2.8 mmol), and the mixture was stirred at room temperature for 90 min. A 10% aqueous solution of sodium thiosulfate (15 mL) was added followed by saturated sodium bicarbonate (15 mL), and the biphasic mixture was stirred at room temperature for 1 h. The layers were separated, the aqueous layer was extracted twice with dichloromethane. The combined organic layers were washed with saturated sodium bicarbonate, and brine, dried over sodium sulfate,fltered and concentrated to afford tert-butyl 4-(oxoethyl)piperidine-l-carboxylate that was used directly without further purification | |
Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With Dess-Martin periodane In dichloromethane at 20℃; for 1.5h; Stage #2: With sodium thiosulfate; Sodium hydrogenocarbonate In dichloromethane; water monomer at 20℃; for 1h; | 22.1 To a solution of tert-butyl 4-(2-hydroxyethyl)piperidine-l-carboxylate (0.6 g, 2.6 mmol) in dichloromethane (30 mL) was added Dess-Martin-periodinane (1.2 g, 2.8 mmol), and the mixture was stirred at room temperature for 90 min. A 10% aqueous solution of sodium thiosulfate (15 mL) was added followed by saturated sodium bicarbonate (15 mL), and the biphasic mixture was stirred at room temperature for 1 h. The layers were separated, the aqueous layer was extracted twice with dichloromethane. The combined organic layers were washed with saturated sodium bicarbonate, and brine, dried over sodium sulfate,fltered and concentrated to afford tert-butyl 4-(oxoethyl)piperidine-l-carboxylate that was used directly without further purification. | |
Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 0.5h; Stage #2: With triethylamine In dichloromethane at -78 - 20℃; for 5h; | 5.1 Dimethyl sulfoxide (7.43 mL, 0.105 mol) was added to oxalyl chloride (5.53 mL, 0.0654 mol) in DCM (244.2 mL) at -78 °C. After 10 min, tert-butyl 4-(2- hydroxyethyl)piperidine-l-carboxylate (from Aldrich, 10.0 g, 0.0436 mol) in DCM (488.4 mL) was added and the resultant mixture was stirred at -78 °C for 30 min. Triethylamine (30.4 mL, 0.218 mol) was then added and the mixture was stirred for 5 h and the temperature allowed to gradually warm up to RT. After being quenched with water, the mixture was extracted with DCM. The organic layers were combined, washed with brine, dried, and evaporated to dryness. LCMS calculated for Ci2H2iN03Na(M+Na)+: m/z = 250.2; Found: 250.0. | |
With Dess-Martin periodane In dichloromethane at 20℃; for 1.5h; | 22.1 To a solution of tert-butyl 4-(2-hydroxyethy Opiperidine- 1 -carboxylate (0.6 g, 2.6 mmol) in dichloromethane (30 mL) was added Dess-Martin-periodinane (1.2 g, 2.8 mmol), and the mixture was stirred at room temperature for 90 min. A 10% aqueous solution of sodium thiosulfate (15 mL) was added followed by saturated sodium bicarbonate (15 mL), and the biphasic mixture was stirred at room temperature for 1 h. The layers were separated, the aqueous layer was extracted twice with dichloromethane. The combined organic layers were washed with saturated sodium bicarbonate, and brine, dried over sodium sulfate.filtered and concentrated to afford tert-butyl 4-(oxoethy piperidine- 1 -carboxylate that was used directly without further purification. | |
With Dess-Martin periodane In dichloromethane at 20℃; Inert atmosphere; | ||
Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 0.833333h; Inert atmosphere; Stage #2: With triethylamine In dichloromethane at 20℃; for 2h; Inert atmosphere; | ||
Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With oxalyl dichloride In dichloromethane; dimethyl sulfoxide at -78℃; for 1.33333h; Stage #2: With triethylamine In dichloromethane; dimethyl sulfoxide at -78 - 20℃; for 2h; | ||
With pyridinium chlorochromate In dichloromethane at 0 - 20℃; for 3h; | ||
With pyridinium chlorochromate In dichloromethane at 20℃; for 3h; | ||
Stage #1: 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -70℃; for 1h; Inert atmosphere; Schlenk technique; Stage #2: With triethylamine In dichloromethane at -78 - 0℃; for 3.5h; Inert atmosphere; Schlenk technique; | ||
With Dess-Martin periodane In dichloromethane at 20℃; for 2h; | B Step B: synthesis of 2-(1-tert-butoxycarbonyl-4-piperidyl)acetaldehyde 2-(1-Tert-butoxycarbonyl-4-piperidyl)ethanol (4.89 g, 21.32 mmol) was dissolved in 50 mL dichloromethane, Dess-Martin oxidant (9.95 g, 23.46 mmol) was added in one portion. The reaction mixture was stirred for 2 h at room temperature. The reaction mixture was poured into a mixture of 250 mL 10% sodium thiosulfate aquesou solution and 150 mL saturated sodium bicarbonate aqueous solution and the mixture was stirred for 45 min. After that, the reaction mixture was extracted with dichloromethane (100 mL×3). The combined organic layer was washed with 150 mL saturated sodium bicarbonate aqueous solution and 150 mL saturated sodium chloride aqueous solution sequentially, dried over anhydrous sodium sulfate, filtered and the filtrate was concnetrated under vacuum to afford 2-(1-tert-butoxycarbonyl-4-piperidyl)acetaldehyde (4.85 g, crude), which was used in next step directly. | |
With phthalic acid dimethyl ester In dichloromethane at 25℃; for 1h; | 9.B Step B: tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate To a solution of tert-butyl 4-(2- hydroxyethyl)piperidine-1-carboxylate (500 mg, 2.18 mmol) in DCM (10 mL) was addedDMP (1.39 g, 3.27 mmol). The reaction mixture was stirred at 25 °C for lh, then the reaction was quenched with NaOH (20 mL, 1M). The resulting mixture was stirred at 25 °C until thesolid dissolved, then extracted with DCM (20 mL x 3). The combined organic layers werewashed with brine (20 mL), dried over MgSO4, and filtered. The filtrate was concentrated in vacuo to give title compound, which was used for next step without further purification. MS(ESI) m/z: 213.1 [M-56+MeCN+Hj ‘H NMR (400 MHz, CDC13): & 9.78 (s, 1H), 4.16 - 4.00 (m, 1H), 2.83 -2.68 (m, 1H), 2.39 (d, J= 6.7 Hz, 2H), 2.13 - 1.99 (m, 1H), 1.70 (d, J=12.5 Hz, 1H), 1.46 (s, 9H), 1.25 - 1.12 (m, 1H) | |
With Dess-Martin periodane In dichloromethane | Synthesis of tert-butyl 4-(formylmethyl)-1-piperidinecarboxylate Synthesis of tert-butyl 4-(formylmethyl)-1-piperidinecarboxylate To a solution of tert-butyl 4-(2-hydroxyethyl)-1-piperidinecarboxylate (1 eq.) in DCM is added DMP (2 eq.). The mixture is stirred at room temperature overnight. After aqueous work-up, the residue is purified by flash chromatography to yield the title compound as a yellow oil. 1H NMR (300 MHz, CDCl3), δ (ppm): 9.78 (br s, 1H), 4.08 (br d, 2H), 2.74 (br t, 2H), 2.39 (d, 2H), 2.12-1.89 (m, 1H), 1.79-1.64 (m, 2H), 1.45 (s, 9H), 1.26-1.10 (m, 2H) | |
With oxalyl dichloride; dimethyl sulfoxide; triethylamine |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With sodium hydroxide; hydroxylamine hydrochloride In methanol at 0 - 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58% | With diethylamino-sulfur trifluoride In dichloromethane at 20℃; for 1h; | |
With diethylamino-sulfur trifluoride In dichloromethane at 0 - 20℃; for 17h; | 22.2 To a solution of tert-butyl 4-(oxoethyl)piperidine-l-carboxylate as obtained in step 1 in dichloromethane (50 mL) was added DAST (1.2 g, 7.8 mmol) at 0 0C. The reaction mixture was warmed to room temperature and stirred for 17 h. A 5% aqueous solution of sodium bicarbonate was added and the layers were separated. The organic layer was washed with saturated sodium bicarbonate, and brine, dried over sodium sulfate, filtered and concentrated to provide tert-butyl 4-(2,2-difiuoroethyl)piperidine-l-carboxylate that was used directly without further purification. | |
With diethylamino-sulfur trifluoride In dichloromethane at 0 - 20℃; | 22.2 To a solution of tert-butyl 4-(oxoethyl)piperidine-l-carboxylate as obtained in step 1 in dichloromethane (50 mL) was added DAST (1.2 g, 7.8 mmol) at 0 0C. The reaction mixture was warmed to room temperature and stirred for 17 h. A 5% aqueous solution of sodium bicarbonate was added and the layers were separated. The organic layer was washed with saturated sodium bicarbonate, and brine, dried over sodium sulfate, filtered and concentrated to provide tert-butyl 4-(2,2-difluoroethyl)piperidine-l-carboxylate that was used directly without further purification. |
With N-ethyl-N-(trifluoromethyl)ethanamine In dichloromethane at 0 - 20℃; for 17h; | 22.2 To a solution of tert-butyl 4-(oxoethyl)piperidine- 1 -carboxylate as obtained in step 1 in dichloromethane (50 mL) was added DAST (1.2 g, 7.8 mmol) at 0 °C. The reaction mixture was warmed to room temperature and stirred for 17 h. A 5% aqueous solution of sodium bicarbonate was added and the layers were separated. The organic layer was washed with saturated sodium bicarbonate, and brine, dried over sodium sulfate, filtered and concentrated to provide terf-butyl 4-(2,2-difluoroethyI)piperidine-l -carboxylate that was used directly without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | Stage #1: Bromoform With potassium <i>tert</i>-butylate; triphenylphosphine In toluene at -20℃; for 0.25h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In toluene at 20℃; for 1h; | |
Stage #1: Bromoform With potassium <i>tert</i>-butylate; triphenylphosphine In toluene at -20℃; for 0.25h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In toluene at 20℃; for 3h; | 5.2 47.6 ml (531 mmol) of tribromomethane and then 59.6 g (531 mmol) of potassium tert-butoxide are added to a solution, cooled to -20° C., of 139.4 g (531 mmol) of triphenylphosphine in 440 ml of toluene. Stirring is continued at -20° C. for 15 minutes and then a solution of 30.1 g (131 mmol) of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate, prepared in stage 5.1., in 240 ml of toluene is added. Stirring is continued at ambient temperature for 3 hours. 300 ml of diethyl ether are added, the solid formed is filtered off and the filtrate is evaporated. The residue is purified by chromatography on silica gel, elution being carried out with dichloromethane, to produce 32.6 g (85 mmol) of product in the form of a yellow oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile Heating / reflux; | 19.1 EXAMPLE 19.1 Tert-butyl-4-allylpiperidine-1-carboxylate To a solution of tert-butyl-4-(2-oxoethyl)piperidine-1-carboxylate (2.13 g, 9.37 mmol) in acetonitrile (30 ml), 1,8-diazabicyclo[5,4,0]undec-7-ene (2.85 g, 18.74 mmol) and methyltriphenyl phosphonium bromide (6.69 g, 18.74 mmol) were added. The reaction was refluxed overnight and diluted with EtOAc, washed with water, brine, dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. Purification by flash chromatography (silica gel, gradient elution with 10% to 20% ethyl acetate/hexanes) provided a yellow oil (1.91 g, 91%). 1H NMR (300 MHz, CDCL3): 5.62-5.80 (m, 1H), 4.94-4.99 (m, 1H), 4.93 (s, 1H), 4.07 (br, 2H), 2.62 (br, 2H), 1.96 (t, 2H), 1.59-1.63 (m, 2H), 1.41 (s, 9H), 1.08-1.12 (m, 1H), 0.96-1.06 (m, 2H). |
37% | Stage #1: Methyltriphenylphosphonium bromide With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran; hexane at 20℃; | 19.1 Example 19.1; 4-Allyl-piperidine-1-carboxylic Acid tert-butyl Ester; To a suspension of methyl triphenylphosphonium bromide (2.6 g, 7.27 mmol) in tetrahydrofuran (20 mL), butyllithium (2M in hexane, 3.63 mL, 7.27 mmol) was added dropwise at -78° C. The reaction mixture was stirred at -78° C. for one hour. The solution of 4-(2-oxo-ethyl)-piperidine-1-carboxylic acid tert-butyl ester (1.5 g, 6.6 mmol) in tetrahydrofuran (20 mL) was added to the above reaction mixture. The resulting mixture was allowed to warm to room temperature and stirred for overnight. The reaction mixture was diluted with ethyl acetate (30 mL), washed with water and brine. The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude residue was purified on silica gel using ethyl acetate:hexane=20%:80% to give the product as colorless oil (550 mg, 37%).1HNMR (300 MHz, CDCl3): (ppm) 5.65 (m, 1H), 4.92 (m, 2H), 3.98 (br, 2H), 2.55 (br, 2H), 1.9 (t, 2H), 1.53 (br, 2H), 1.36 (s, 9H), 0.98 (m, 2H), 0.79 (m, 1H) |
With potassium hexamethylsilazane In tetrahydrofuran |
1.38 g | With potassium hexamethylsilazane In tetrahydrofuran at 0 - 20℃; for 18h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With PTAP In tetrahydrofuran at 10℃; for 3h; | 53.1 EXAMPLE 53; Tert-butyl 4-(8-(2-methyl-6-(methylsulfonyl)pyridin-3-ylamino)imidazo[l,2- b]pyridazin-3-yl)piperidine-l-carboxylateStep 1: Tert-butyl 4-(l-bromo-2-oxoethyl)piperidine-l-carboxylate[0388] A l L round-bottom flask was charged with a solution of tert-butyl 4-(2- oxoethyl)piperidine-l-carboxylate (23 g, 101.32 mmol, 1.00 equiv), PTAP (40 g) in tetrahydrofuran (500 mL). The resulting solution was stirred at 100C for 3 h. Upon completion, the reaction was quenched with brine (IL). The resulting mixture was extracted with ethyl acetate (3x300 mL). Combine organic layers were dried over anhydrous sodium sulfate and concentrated under vacuum affording tert-butyl 4-(l- bromo-2-oxoethyl)piperidine-l-carboxylate as yellow oil (25 g, 65%). |
50% | With phenyltrimethylammonium tribromide In tetrahydrofuran at 0℃; for 0.75h; | |
With phenyltrimethylammonium tribromide In tetrahydrofuran Cooling; | To 4-(2-oxoethyl)piperidine-l-carboxylic acid tert-butyl ester (2g) in THF (5OmL) at ice bath temperature was added phenyltrimethylammoniumtribromide (3.3Ig) and the reaction stirred 50 min. Water (1OmL) was added and the mixture partially concentrated in vacuo, extracted with DCM (3x 5OmL), dried, filtered and concentrated in vacuo. To the residue was added ethanol (100ml) and thiourea (1.34g) and the reaction mixture heated 2h at 80 degrees, cooled, concentrated in vacuo, dissolved in DCM, washed with sodium hydrogen carbonate, dried and concentrated in vacuo to give the title compound (1.6g). LCMS: RT = 1.3 min API-ES, Pos, 284 |
With phenyltrimethylammonium tribromide | ||
32 g | With N,N,N-trimethylanilinium bromide In tetrahydrofuran at 0 - 25℃; for 12h; | c c. Put compound 3 (40 g, 0.176 mol)Dissolved in tetrahydrofuran (1 L),Dissolve in tetrahydrofuran (500mlL) at 0 ° CPTAB (99 g, 0.264 mol).After the addition, the mixture was stirred at room temperature at 25 ° C for 12 hours.TLC (petroleum ether / ethyl acetate volume ratio = 5/1) showed the end of the reaction.The mixture was freed from the solvent tetrahydrofuran under reduced pressure,Add water (500 mL),The mixture was extracted with ethyl acetate (200 mL x 3).The organic phase was dried by adding sodium sulfate,Filtration and spin-drying gave the crude compound 4 (32 g) as a pale yellow oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: N-(benzyloxycarbonyl)phosphonoglycine trimethyl ester With N,N,N',N'-tetramethylguanidine In tetrahydrofuran at -78℃; for 0.166667h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at -78 - 20℃; for 2h; | c; 20.D To a solution of Cbz-α-phosphonoglycine trimethyl ester, (2.8 g, 8.45 mmol) in THF at -78° C. is added 1,1,3,3-tetramethyl-guanidine (1.022 ml, 8.14 mmol). After 10 minutes, the aldehyde 20-C (1.76 g, 7.76 mmol) is added. The solution is then placed in an ice bath at 0° C. for 1 hour, and then allowed to warm to room temperature and stirred one more hour. The solution is diluted with EtOAc, washed with 1M NaHSO4, dried (MgSO4) and concentrated in vacuo. The residue is purified by chromatography (ISCO) with Ethyl acetate/Hexane 0 to 100% to afford 20-D as a yellow oil. MS m/z 333.2 (M+1), 1H NMR (CDCl3, 400 MHz) δ. 7.35-7.33 (5H, m), 6.63 (1H, t, J=8 Hz), 6.30 (1H, bs), 5.12 (2H, s), 4.10-4.04 (2H, m), 3.73 (3H, s), 2.67-2.62 (2H, m), 2.14 (2H, t, J=6.8 Hz), 1.63-1.46 (3H, m), 1.43 (9H, s), 1.14-1.06 (2H, m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
MeNH2 (1.41 mL of a 2.0 M solution in THF, 2.82 mmol) was added to a stirred solution of 4-(2-oxoethyl)piperidine-l-carboxylic acid tert-butyl ester (639 mg, 2.81 mmol) in anhydrous PhMe (2 mL). After 30 min, the solution was concentrated in vacuo, then anhydrous THF (2 mL) and anhydrous MeOH (2 mL) were added. The stirred solution was treated with NaBH4 (128 mg, 3.38 mmol). After 3 h, the solvents were removed under reduced pressure and the residue partitioned between EtOAc (25 mL) and H2O (20 mL). The organic layer was washed EPO <DP n="18"/>with brine (20 mL), dried (MgSO4), filtered, and concentrated to furnish the title compound: deltaH (CDCl3) 1.00-1.10 (m, 2H), 1.35-1.45 (m, 10H), 1.50-1.65 (m, 4H), 2.39 (s, 3H), 2.50-2.70 (m, 4H), 3.90-4.10 (m, 2H). | ||
Example 221: 4-(2-[3-(4-Methanesulfonylphenyl)-[l,2,4]oxadiazol-5-yl]methylamino} ethyl)piperidine-l-carboxylic acid tert-butyl ester: A solution of 4-(2-oxoethyl)piperidine-l-carboxylic acid tert-butyl ester (300 mg, 1.32 mmol) in toluene (1 mL) and methylamine (0.66 mL of a 2 M solution in toluene) was stirred at rt for 1 h and the solvent removed. The residue was dissolved in 1: 1 THF/MeOH (2 mL) and sodiumborohydride (60 mg, 1.58 mmol) added. After stirring overnight, the mixture was diluted with EtOAc (50 mL) and washed with water (10 mL), brine (10 mL) and dried (MgSO4). Evaporation of the solvent afforded crude 4-(2-methylaminoethyl)piperidine-l-carboxylic acid tert-butyl ester which was dissolved in anhydrous DMF (1 mL) and added to 5-chloro-3-(4- methanesulfonylphenyl)-[l,2,4]oxadiazole (Preparation 47, 100 mg, 388 mumol), followed by triethylamine (54 muL, 388 mumol). The mixture was heated at 12O0C for 2 h, cooled and the solvent removed. The residue was purified by RP-HPLC (CH3CN-H2O) to afford the title compound: RT = 3.95 min (method 2); m/z (ES+) = 465.1 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: oxazolo[4,5-c]pyridine With isopropylmagnesium chloride In tetrahydrofuran at 0℃; for 1h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at 0 - 20℃; for 16h; Stage #3: With water; ammonium chloride In tetrahydrofuran | 7 Preparation 7; 4-(2-Hydroxy-2-oxazolo[4,5-c]pyridin-2-ylethyl)piperidine-l-carboxylic acid tert-my ester; Z-PrMgCl (0.44 mL of a mmol/mL solution in THF, 0.88 mmol) was added dropwise to a stirred solution of oxazolo[4,5-c]pyridine (105 mg, 0.87 mmol) in anhydrous THF (3 mL) at 0 0C. After 1 h, a solution of 4-(2-oxo-ethyl)piperidine-l-carboxylic acid tert-bυtyl ester (198 mg, 0.87 mmol) in anhydrous THF (2 mL) was added, then the mixture was allowed to warm to 200C over 16 h, before being quenched with saturated aqueous NH4Cl (10 mL). The layers were separated, then the aqueous phase was extracted with EtOAc (3 x 15 mL). The combined organic extracts were dried (MgSO4), filtered, and concentrated in vacuo. Flash chromatography (EtOAc) of the residue furnished the title compound: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -10℃; for 0.25h; Stage #2: methyl (4-pyridyl) ketone In tetrahydrofuran; hexane at -78℃; for 0.5h; Stage #3: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran; hexane for 2h; | 106 Diisopropylamine (150 μL, 1.46 mmol) in anhydrous THF (2 mL) was cooled to -1O0C and n-butyllithium (560 μL of a 2.5 M solution in hexane, 1.40 mmol) was added. After stirring for 15 min, the solution was cooled to -780C and l-pyridin-4-ylethanone (154 μL, 1.40 mmol) introduced. After 30 min, a solution of 4-(2-oxoethyl)piperidine-l-carboxylic acid tert-butyl ester (254 mg, 1.12 mmol) in anhydrous THF (1.5 mL) was added and the reaction stirred for a further 2 h before being quenched with saturated aqueous NaHCO3 (2 mL). Following dilution with EtOAc (50 mL), the organic phase was separated and dried (MgSO4) then evaporated. The residue was purified by column chromatography (EtOAc) to give the title compound: RT = 3.15 min; m/z (ES+) = 349.2 [M+ H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine In 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran; dimethyl sulfoxide | 7.A N-tert-Butoxycarbonyl-4-piperidylacetaldehyde Step A N-tert-Butoxycarbonyl-4-piperidylacetaldehyde A solution of oxalyl chloride (2.4 mL, 27.5 mmol) in 125 mL DCM was cooled to -78° C. and DMSO (3.3 mL, 47.1 mmol) was added slowly. After 10 min a solution of 2-(N-tert-butoxycarbonyl-4-piperidyl)ethanol (4.5 grams, 19.6 mmol) in 10 mL DCM was added. The mixture was stirred for 20 min then triethylamine (13.6 mL, 98.1 mmol) was added and the mixture was warmed to room temperature. After 30 min the mixture was diluted with ethyl acetate and washed with water (3*). The organic portion was dried over sodium sulfate and concentrated. Flash chromatography (3/1 hexane/EtOAc) afforded the desired aldehyde. 1H NMR (400 MHz, CDCl3). δ1.13-1.43 (m, 2H), 1.48 (s, 9H), 1.68-1.77 (m, 2H), 2.04-2.11 (m, 1H), 2.38-2.41 (d, 2H), 2.71-2.8 (m, 2H), 4.04-4.14 (m, 2H), 9.8 (s, 1H). | |
3.7 grams (83%) | With triethylamine In 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran; dimethyl sulfoxide | 164.A Step A Step A N-tert-Butoxycarbonyl-4-piperidylacetaldehyde A solution of oxalyl chloride (2.4 mL, 27.5 mmol) in 125 mL DCM as cooled to -78 C and DMSO (3.3 mL, 47.1 mmol) was added slowly. After 10 in a solution of 2-(N-tert-butoxycarbonyl-4-piperidyl)ethanol (4.5 grams, 19.6 mol) in 10 mL DCM was added. The mixture was stirred for 20 min then triethylamine (13.6 mL, 98.1 mmol) was added and the mixture was warmed to room temperature. After 30 min the mixture was diluted with ethyl acetate and washed with water (3*). The organic portion was dried over sodium sulfate and concentrated. Flash chromatography (3/1 hexane/EtOAc) afforded 3.7 grams (83%) of the desired aldehyde. 1H NMR (400 MHz, CDCl3). δ1.13-1.43 (m, 2H), 1.48 (s, 9H), 1.68-1.77 (m, 2H), 2.04-2.11 (m, 1H), 2.38-2.41 (d, 2H), 2.71-2.8 (m, 2H), 4.04-4.14 (m, 2H), 9.8 (s, 1H). |
With N-ethyl-N,N-diisopropylamine In hexane; dichloromethane; water; dimethyl sulfoxide; ethyl acetate | 292.B Step B Step B 1-t-Butyloxycarbonyl-4-formylmethyl-piperidine Oxalyl chloride (2.2 mL, 25 mmol) was added to 75 mL of anhydrous CH2Cl2 at -78° C. DMSO (3.5 mL, 50 mmol) was then added dropwise over 5 min, and the resulting mixture was stirred for 15 min. 1-t-Butyloxycarbonyl-4-(2-hydroxyethyl)piperidine (2.29 g, 10 mmol, step A) was dissolved in 5 mL of anhydrous CH2Cl2 and added over 10 min to the above mixture. After stirring 30 min, DIEA (17.4 mL, 100 mmol) was added over 10 min. The mixture was then warmed to 0° C. and maintained at that temperature for 1 hr. After quenching with water, the reaction mixture was diluted with 75 mL of CH2Cl2 and the layers were separated. The organic phase was washed with 3*50 mL of water and dried over anhydrous magnesium sulfate. Solvent removal gave an oil, which was purified on silica gel using 20% EtOAc in hexane to give 2.05 g of the desired aldehyde which hardened overnight into an oily solid. NMR: 1.2 (m, 2H),1.5~1.7 (m, 3H), 2.15 (d, 2H, J=3), 2.75 (m, 2H), 4.1 (m, 2H) 9.8(s, 1H). |
2.25 g (84%) | With triethanolamine In dichloromethane; dimethyl sulfoxide | 33.A Step A Step A ((1-t-Butoxycarbonyl)piperidin-4-yl)acetaldehyde A solution of oxalyl chloride (1.23 mL, 14.1 mmol) in 50 mL CH2Cl2 was cooled to -78° C. DMSO (2.0 mL, 28.3 mmol), was added slowly via syringe. After 10 min, 1-(t-butoxycarbonyl)-4-(2-hydroxyethyl)piperidine (2.7 g, 11.8 mmol, from EXAMPLE 113, Step A) in 15 mL CH2Cl2 was added. The cold mixture was stirred for an additional 20 min then TEA (8.2 mL, 59 mmol) was added. The mixture was warmed to rt and stirred for 1.5 h then diluted with 300 mL CH2Cl2. The organic phase was washed with 1 M NaOH then dried over Na2SO4 and concentrated. Flash chromatography (125 g silica, 2.5/1 hexane/EtOAc) afforded 2.25 g (84%) of the title compound: 1H NMR (300 MHz) a 1.1-1.2 (m, 2H), 1.45 (s, 9H), 1.65-1.75 (m, 2H), 1.99-2.13 (m, 1H), 2.38-2.4 (d, 2H), 2.65-2.8 (m, 2H), 4.03-4.15 (m, 2H), 9.78 (s, 1H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.9% | Stage #1: (4-fluorobenzyl)(triphenyl)phosphonium bromide With n-butyllithium In tetrahydrofuran; pentane at -10℃; for 0.5h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran; pentane at 20℃; for 6h; | 88 To a suspension of benzyl triphenyl phosphonium bromide (1.0 equiv) in dry THF, 2M butyllithium in pentane (1.35 equiv) was added at -100C. After stirred for 30min, the solution of piperidinyl acetaldehyde (1.05 equiv) in THF was added dropwise. The mixture was allowed to warm to room temperature and stirred for another 6 hours. After removing THF, the residue was partitioned between ether and water. The combined organic layers were washed with brine, dried over anhydrous sodium sulfate. The product was purified with flash chromatography on silica gel (30% ethyl acetate in hexanes). IH NMR was used to confirm the purity of the product.; 4-[2-(4-Fluoro_phenyl)-allyl]-piperidine-l-carboxylic aclcι tert-butyl ester was obtained from 4-fluoro-benzyl triphenyl phosphorium bromide (2.20mmol, Ig), 2M butyllithium in pentane (2.98mmol, 1.5ml), l-(2-oxo-ethyl)-piperine-4-carboxylic acid tert-butyl ester (2.3 Ommol, 0.53g) in THF (30ml) as yellow foam (0.712g 96.9%). 1H NMR (300MHz, CDC13): δ(ppm) 7.11-7.26 (m, 2H), 6.87-6.97 (m, 2H), 6.20-6.38 (m, IH), 5.96-6.06 and 5.56-5.62 (m, IH), 4.00-4.08 (m, 2H), 2.61(t, 2H),2.04-2.16 (m, 2H ), 1.57-1.64 (m, 3H), 1.41 (s, 9H), 1.08- 1.17(m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
118 mg (72%) | With triethanolamine; triphenylphosphine In dichloromethane | 74.A Step A Step A 1-(t-Butoxycarbonyl)-4-(3,3-dibromoprop-2-enyl)piperidine To a solution of 286 mg (0.86 mmol) of carbon tetrabromide in 4 mL of CH2Cl2 at -10° C. was added 339 mg (1.29 mmol) of triphenylphosphine. After 10 min, a solution of 98 mg (0.43 mmol) of ((1-t-butoxycarbonyl)piperidin-4-yl)acetaldehyde (from EXAMPLE 33, Step A) and 0.060 mL (0.43 mmol) of TEA in 2 mL of CH2Cl2 was added. After stirring at rt for 2 h, the reaction mixture was concentrated. The residue was purified by flash chromatography eluding with 9:1 v/v hexanes/EtOAc, then 1:1 v/v hexanes/EtOAc to give 118 mg (72%) of the title compound: 1H NMR (500 MHz) δ 1.14-1.22 (2H), 1.47 (s, 9H), 1.57-1.60 (m, 1H), 1.67 (br d, J=12.6,22H), 2.08 (t, J=7.1,22H), 2.70 (t, J=12.7,22H), 4.10 (br d, J=12.6, 2H), 6.42 (t, J=7.4, 1H). |
With triphenylphosphine | ||
With triphenylphosphine |
With triphenylphosphine In dichloromethane at 0℃; for 1.33333h; | 5.1 Carbon tetrabromide (46.7 g, 141 mmol) was dissolved in 200 mL dichlororaethane. The solution was cooled in an ice-water bath and triphenylphosphine (73.9 g, 282 mmol) in 200 mL dichloromethane was introduced via an addition funnel over 20 min. The reaction mixture was stirred at 0°C for 10 min and a solution of tert-butyl 4-(2-oxoethyl)piperidine-l -carboxylate (16 g, 70.4 mmol) in 100 mL dichloromethane was added via an addition funnel. The solution was stirred at 0°C for 1 hour. Water (250 mL ) was added and aqueous layer was extracted 3 times with 100 mL dichloromethane. The combined organic layer was washed with brine, dried over sodium sulfate, filtered and concentrated. 300 mL ether was added to the residue, and the resulting suspension was filtered. The solid was washed 3 times with 150 mL ether. The combined filtrate was concentrated and passed through a plug of silica gel, washed thoroughly with 10% acetone/hexanes to afford yellow oil which was used without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With molecular sieve In tetrahydrofuran; dichloromethane at 20℃; for 1h; | 44 Example 44; 4-{2-[4-(4-Sulfamoylphcnyl)pipcrazin-l-yl]cthyl}pipcridinc-l-carboxylic acid tert-butyl ester hydrochloride; EPO A mixture of 4-fluorobenzenesulfonamide (1.00 g, 5.71 mmol) and piperazine (2.46 g, 28.54 mmol) in water (12 mL) was heated at 1000C for 2Oh. The resulting precipitate was collected filtration and washed with water and toluene to give 4-piperazin-l- ylbenzenesulfonamide: RT = 0.49 min; m/z (ES+) = 242.13 [M+H]+. A solution of 4-piperazin- 1-ylbenzenesulfonamide (0.46 g, 1.89 mmol) and 4-(2-oxoethyl)piperidine-l-carboxylic acid tert-butyl ester (0.43 g, 1.89 mmol) in DCM (50 mL) and THF (7 mL) with molecular sieves (0.90 g) was stirred under argon at rt for Ih. Sodium acetoxyborohydride (0.52 g, 2.46 mmol) was added and the reaction mixture was stirred for a further 2.5h. The reaction mixture was quenched with saturated NaHCO3 solution and extracted with EtOAc. The organic extracts were washed with brine, dried (MgSO4) and the solvent was removed under vacuum. The resulting solid was purified by recrystallisation (EtOAc) then dissolved in THF and 1 M HCl in dioxane (0.95 equivalents), the solvent was removed under vacuum and the resulting solid was washed with Et2O to afford the title compound: RT = 2.51 min; m/z (ES+) = 453.33 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 1-(4-Nitrophenyl)piperazine; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In methanol at 20℃; for 71h; Stage #2: With sodium tetrahydroborate In methanol for 3h; Stage #3: With water; sodium hydrogencarbonate In ethyl acetate | 1 Intermediate 1; 2-[4-(4-Aminophenyl)piperazin-l-yl]ethyl}piperidine-l-carboxylic acid tert-butyl ester; A solution of 4-(2-oxoethyl)piperidine- 1-carboxylic acid tert-butyl ester (0.50 g, 2.20 mmol) and l-(4-nitrophenyl)piperazine (0.35 g, 1.70 mmol) in anhydrous MeOH (5 mL) was stirred for 71h at rt, then NaBH4 (0.13 g, 3.39 mmol) was added and reaction was stirred for a further 3h. The solvent was removed under vacuum and the resulting residue was partitioned between EtOAc and saturated NaHCO3 solution. The aqueous phase was extracted with twice EtOAc, the organic extracts were combined, dried (MgSO4) and adsorbed onto SiO2. The adsorbed sample was purified by flash chromatography eluting with EtOAc to give 4-{2-[4-(4- nitrophenyl)piperazin-l-yl]ethyl}cyclohexanecarboxylic acid tert-butyl ester (0.54 g, 1.30 mmol), which was taken up in EtOH (25 mL), 10% palladium on carbon was added and the mixture was stirred under an hydrogen atmosphere at rt for 2Oh. The reaction mixture was filtered through celite and the solvent was removed under vacuum to afford the title compound: δH (400 MHz, CHCl3) 1.17 (2H, m), 1.48 (9H, s), 1.50 (IH, m), 1.69 (2H, d), 2.45 (2H, m), 2.62 (4H, br s), 2.71 (2H, m), 3.09 (4H, m), 3.44 (2H, br s), 4.09 (2H, br s), 6.68 (2H, d), 6.84 (2H, d). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 2-phenylpyrazolo[3,4-c]quinolin-4(5H)-one With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran; hexane at 0℃; for 0.0833333h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran; hexane at -78 - 20℃; for 0.5h; | 8.B Part B2-Phenyl-2,5-dihydro-4H-pyrazolo[3,4-c]quinoline-one (574 mg, 2.20 mmol) was combined with N, N, N', N'-tetrarnethylethylenediamine (1.5 mL), and tetrahydrofuran (24 mL) under an atmosphere of nitrogen. The mixture was chilled to 0 0C. A solution of n- butyllithium in hexanes (2.0 mL of 2.5 M) was added dropwise. After the addition was complete the reaction mixture was stirred for 5 minutes at 0 0C and then cooled to -78 °C. To the cooled solution was added ført-butyl 4-(2-oxoethyl)piperidine-l -carboxylate (1.0 g, 4.4 mmol). The reaction mixture was warmed to ambient temperature and stirred for 30 EPO minutes before quenching with saturated aqueous ammonium chloride. The aqueous layer was extracted with chloroform. The combined organic extracts were dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford a yellow oil. The oil was purified by automated flash chromatography (AnaLogix, eluted with a gradient of 0 - 30% CMA in chloroform) to provide an oily solid. The oily solid was stirred in acetonitrile and filtered to provide 450 mg of tert-butyl 4-[2-hydroxy-2-(4-oxo-2-phenyl- 4,5-dihydro-2H'-pyrazolo[3,4-c]quinolin-l-yl)ethyl]piperidine-l-carboxylate as a white solid, mp 253-254 0C. MS (APCI) m/z 489 (M + H)+; Anal, calcd for C28H32N4O4: C, 68.83; H, 6.60; N, 11.47. Found: C5 68.49; H, 6.83; N, 11.67. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: piperazine; 2,4-difluoro-1-(methylsulfonyl)benzene In <i>tert</i>-butyl alcohol at 20℃; for 72h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With sodium tris(acetoxy)borohydride In dichloromethane at 20℃; for 168h; | 12 Example 12; 4-{2-[4-(5-Fluoro-2-methanesulfonylphenyl)piperazin-l-yl]ethyl} piperidinc- 1-carboxylic acid tert-butyl ester; A solution of 2,4-difluorophenylmethylsulfone (0.10 g, 0.52 mmol) and piperazine (45 mg, 0.52 mmol) in tert-BuOH (2 mL) was stirred for 72h at rt. The reaction mixture was diluted with MeOH and purified by ion-exchange chromatography (SCX) to give l-(5-fluoro-2- methanesulfonylphenyl)piperazine. To a solution of l-(5-fluoro-2-methane sulfonylphenyl)piperazine (75 mg, 0.25 mmol) and 4-(2-oxoethyl)piperidine-l -carboxylic acid tert-butyl ester (157 mg, 0.75 mmol) in DCM (2 mL) was added sodium triacetoxy borohydride (52 mg, 0.38 mmol) and the mixture was stirred at rt for 7 days. The reaction mixture was diluted with DCM , washed with water and purified by flash chromatography eluting with EtOAc to afford the title compound: RT = 2.64 min; mlz (ES+) = 470.14 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 4-[4-(methylsulfinyl)phenyl]piperazine-1-carboxylic acid test-butyl ester; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With acetic acid In methanol at 20℃; for 20h; Stage #2: With sodium tetrahydroborate In methanol for 3h; | 51 Example 51; 4-{2-[4-(3-Fluoro-4-mcthancsulfonylphcnyl)pipcrazin-l-yl] cthyljpipcridinc- 1-carboxylic acid ferf-butyl ester; A solution of l-(4-methanesulfinylphenyl)piperazine (46 mg, 0.22 mmol) and 4-(2- oxoethyl) piperidine-1-carboxylic acid tert-bυtyl ester (50 mg, 0.22 mmol) in anhydrous MeOH (2 mL) with glacial AcOH (1 drop) was stirred at rt under argon for 20 h. NaBH4 (17 mg, 0.44 mmol) was added to the mixture and the reaction was stirred for a further 3h. The reaction was quenched with water and extracted with DCM. The organic phase was collected and purified by flash chromatography eluting with 1:4:95 NH3:MeOH:DCM to afford the title compound: RT = 2.54 min; mlz (ES+) = 436.33 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With molecular sieve In dichloromethane at 20℃; for 1h; | 46 Example 46; 4-{2-[4-(4-(Pyrrolidine-l-sulfonyl)phenyl)piperazin-l-yl]ethyl}piperidine-l- carboxylic acid tert-butyl ester; To a solution of pyrrolidine (95 μL, 1.13 mmol) and Et3N (158 μL, 1.13 mmol) in DCM (2.5 mL) was added 4-fluorobenzenesulfonyl chloride (200 mg, 1.03 mmol) and the reaction was stirred at rt for 2h. The reaction mixture was diluted with DCM, then washed with water then brine, dried (MgSO4) and the solvent was removed under vacuum to give l-(4- fluorobenzenesulfonyl)pyrrolidine: RT = 3.06 min; m/z (ES+) = 230.13 [M+H]+. A mixture of EPO piperazine (47 mg, 0.55 mmol) and l-(4-fluorobenzenesulfonyl)pyrrolidine (25 mg, 0.11 mg) in water (3 mL) was heated in a microwave at 15O0C for 30 min. The resulting solid was collected by filtration, washed with water and toluene to give l-[4-(pyrrolidine-l-sulfonyl) phenyl]piperazine: RT = 2.01 min; m/z (ES+) = 296.15 [M+H]+. A solution of l-[4-(pyrrolidine- 1-sulfonyl) phenyl]piperazine (24 mg, 80 μmol) and 4-(2-oxoethyl)piperidine-l-carboxylic acid tert-butyl ester (18 mg, 80 μmol) in DCM (5 mL) with molecular sieves 50 mg) was stirred under argon at rt for Ih. Sodium acetoxyborohydride (22 mg, 104 μmol) was added and the reaction mixture was stirred for a further 2.5h. The reaction mixture was quenched with saturated NaHCO3 solution and extracted with EtOAc. The organic extracts were washed with brine, dried (MgSO4) and the solvent was removed under vacuum. The resulting solid was purified by flash chromatography eluting with 5:95 MeOH:DCM to afford the title compound: RT = 2.69 min; m/z (ES+) = 507.33 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 1-(3-fluoro-4-methylsulfanylphenyl)piperazine; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With acetic acid In methanol at 20℃; for 20h; Stage #2: With sodium tetrahydroborate In methanol for 3h; Stage #3: With water; sodium hydrogencarbonate In methanol | 52 Example 52; 4-{2-[4-(3-Fluoro-4-mcthancsulfonylphcnyl)pipcrazin-l-yl]cthyl}pipcridinc- 1-carboxylic acid terf-butyl ester; EPO A solution of l-(3-fluoro-4-methylsulfanylphenyl)piperazine (183 mg, 0.81 mmol) and 4-(2-oxoethyl) piperidine-1-carboxylic acid tert-mty ester (368 mg, 1.62 mmol) in anhydrous MeOH (5 mL) with glacial AcOH (1 drop) was stirred at rt under argon for 20 h. NaBH4 (92 mg, 2.43 mmol) was added to the mixture and the reaction was stirred for a further 3h. The reaction was quenched with saturated Na2HCO3 solution and extracted with DCM. The organic phase was collected, washed with brine, dried (MgSO4), the solvent was removed under vacuum and the resulting solid was purified by flash chromatography eluting with 50:50 EtOAc:hexane to give 4-{2-[4-(3-fluoro-4-methylsulfanylphenyl)piperazin-l- yl]ethyl}piperidine-l-carboxylic acid tert-butyl ester: RT = 2.84 min; mlz (ES+) = 438.30 [M+H]+. To a solution of 4-{2-[4-(3-fluoro-4-methylsulfanylphenyl)piperazin-l-yl]ethyl} piperidine-1-carboxylic acid tert-mγ ester (64 mg, 0.15 mmol), NaMoO4 (3.5 mg, 15 μmol) and tributylamine (3.5 μL, 15 μmol) in toluene (1 mL) was added 27% H2O2 solution (10 μL, 79 mmol) followed by glacial AcOH (47.5 μL, 0.80 mmol) and finally 27% H2O2 solution (27 μL, 211 μmol). The reaction was warmed to 6O0C for 30 min, then quenched with 10% Na2SO3 solution and the aqueous phase was basifed to pH8 with 1 M NaOH solution. The mixture was extracted with EtOAc, the organic phase was dried (MgSO4), solvent was removed under vacuum and the resulting residue was purified by flash chromatography eluting with EtOAc then 10:90 MeOH:DCM to afford the title compound: RT = 2.57 min; mlz (ES+) = 470.35 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 1-(4-ethylsulfanylphenyl)piperazine; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With acetic acid In methanol at 20℃; for 20h; Stage #2: With sodium tetrahydroborate In methanol for 3h; Stage #3: With water In methanol | 54 Example 54; 4-{2-[4-(4-Ethancsulfonylphcnyl)pipcrazin-l-yl]cthyl}pipcridinc-l- carboxylic acid ferf-butyl ester; A solution of l-(4-ethylsulfanylphenyl)piperazine (80 mg, 0.36 mmol) and 4-(2- oxoethyl) piperidine-1-carboxylic acid tert-bυtyl ester (82 mg, 0.36 mmol) in anhydrous MeOH (2 mL) with glacial AcOH (1 drop) was stirred at rt under argon for 20 h. NaBH4 (27 mg, 0.72 mmol) was added to the mixture and the reaction was stirred for a further 3h. The reaction was quenched with water and extracted with DCM. The organic phase was collected, dried (MgSO4), the solvent was removed under vacuum and the resulting solid was purified by flash chromatography eluting with 1:2:97 NH3:MeOH:DCM to give 4-{2-[4-(4-ethyl sulfanylpheny^piperazin-l-y^ethyljpiperidine-l-carboxylic acid tert-bυtyl ester: RT = 3.14 min; mlz (ES+) = 448.36 [M+H]+. To a solution of 4-{2-[4-(4-ethylsulfanylphenyl)piperazin-l- yl]ethyl}piperidine-l-carboxylic acid tert-bυtyl ester (90 mg, 208 μmol), NaMoO4 (5 mg, 20.8 μmol) and tributylamine (5 μL, 20.8 μmol) in toluene (1 mL) was added 27% H2O2 solution (20 μL, 160 μmol) followed by glacial AcOH (13 μL, 229 μmol) and finally 27% H2O2 solution (32 μL, 256 μmol). The reaction was quenched after 10 min with 10% Na2SO3 solution and extracted with DCM. The organic phase was dried (MgSO4) and purified by flash chromatography eluting with 1:2:97 NH3:MeOH:DCM to afford the title compound: RT = 2.61 min; mlz (ES+) = 466.25 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
32% | Stage #1: 4-(4-methylsulfanylphenyl)piperidine hydrochloride; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With triethylamine In methanol at 20℃; for 20h; Stage #2: With sodium tetrahydroborate In methanol at 0℃; for 1h; Stage #3: With water In dichloromethane | 56 Example 56; 4-{2-[4-(4-Methylsulfanylphenyl)piperidin-l-yl]ethyl}piperidine-l-carboxylic acid tert-butyl ester; To a solution of 4-(4-methylsulfanylphenyl)piperidine hydrochloride (0.244g, 1.OOmmol) in MeOH (1OmL) was added NEt3 (0.14mL, lmmol) followed by N-boc-piperidinyl- 4-acetaldehyde (0.273g, 1.2mmol). The mixture was allowed to stir at rt for 2Oh. The reaction was cooled to O0C and treated with sodium borohydride (0.057g, 1.5mmol). The reaction was stirred for Ih and the solvent removed in vacuo. DCM (3OmL) and water (2OmL) was added and EPO the two layers separated. The aqueous phase was further extracted with DCM and the combined organic phases washed with brine, dried (MgSO4) and the solvent removed in vacuo. The crude mixture was purified by flash chromatography with EtOAc as eluent to afford the title compound (0.132g, 32%): RT = 2.86 min; m/z (ES+) = 418.6 [M+ H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | Stage #1: 4-[4-(methylsulfonyl)phenyl]piperidine; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In methanol at 20℃; for 20h; Stage #2: With sodium tetrahydroborate In methanol at 0℃; for 1h; Stage #3: With water In dichloromethane | 55 Example 55; 4-{2-[4-(4-Methanesulfonylphenyl)piperidin-l-yl]ethyl}piperidine-l- carboxylic acid tert-butyl ester; A solution of 4-(4-methanesulfonylphenyl)piperidine-l-carboxylic acid tert-butyl ester (0.276g, 0.813mmol) in DCM (15mL) was treated with TFA (1.5mL) and the mixture stirred at rt for 0.5h. DCM (3OmL) was added and the organic layer washed with saturated Na2CO3 solution, brine, dried (MgSO4) and the solvent removed in vacuo to yield 4-(4- methanesulfonylphenyl)piperidine (0.19g, 97%). To a solution of the solid (0.189g, 0.79mmol) in MeOH (5mL) was added N-boc-piperidinyl-4-acetaldehyde (0.215g, 0.95 mmol) and the mixture allowed to stir at rt for 2Oh. The reaction was cooled to 0 0C and treated with sodium borohydride (0.045g, 1.18mmol). The reaction was stirred for Ih and the solvent removed in vacuo. DCM (25mL) and water (1OmL) were added and the two layers separated. The aqueous phase was further extracted with DCM and the combined organic phases washed with brine, dried (MgSO4) and the solvent removed in vacuo. The crude mixture was purified by flash chromatography with 1% NEt3, 2%MeOH / EtOAc as eluent to afford the title compound (0.252g, 79%): RT = 2.80 min; m/z (ES+) = 451.4 [M+ H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
7% | Stage #1: (3S)-3-methyl-1-[4-(methylsulfonyl)phenyl]piperazine; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In methanol at 20℃; for 20h; Stage #2: With sodium tetrahydroborate In methanol for 1h; Stage #3: With water In ethyl acetate | 57 Example 57; 4-{2-[(S)-4-(4-Methanesulfonylphenyl)-2-methylpiperazin-l-yl] cthyl}pipcridinc-l-carboxylic acid tert-butyl ester; A solution of (S)-I -(4-methanesulfonylphenyl)-3-methylpiperazine (0.387g, 1.52mmol) andN-Boc-piperidinyl-4-acetaldehyde (0.692g. 3.05mmol) in MeOH (1OmL) was allowed to stir at room temperature for 2Oh. The mixture was cooled to O0C and treated with sodium borohydride (0.191g, 5.03mmol). The reaction was stirred for an additional Ih and the solvent removed in vacuo. EtOAc (25mL) and water (1OmL) was added and the two layers separated. The aqueous phase was further extracted with DCM and the combined organic phases washed with brine, dried (MgSO4) and the solvent removed in vacuo. The crude mixture was purified by flash chromatography with 5% NEt3 / EtOAc as eluent to afford the title compound (0.047g, 7%): RT = 2.59 min; m/z (ES+) = 466.4 [M+ H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 4 A molecular sieve In dichloromethane at 20℃; for 1h; | 82 Example 82; 4-{2-[4-(6-Chloropyridin-3-yl)piperazin-l-yl]ethyl}piperidine -1-carboxylic acid terf-butyl ester; A solution of 4-(6-chloropyridin-3-yl)piperazine- 1-carboxylic acid tert-butyl ester (0.15g, 0.5 mmol) in DCM (5 mL) was treated with TFA (1 mL) and the mixture stirred at rt for 4h. DCM (20 mL) was added and the organic layer washed with 2M NaOH solution, brine, dried (MgSO4) and the solvent removed in vacuo to yield l-(6-chloro pyridin-3-yl)piperazine as a yellow solid (0.067g, 68%). The solid was dissolved in DCM (8mL) and treated with N-boc- piperidinyl-4-acetaldehyde (0.077g, 0.34 mmol) and 4A molecular sieves (O.lg) at rt. The solution was allowed to stir for Ih then treated with NaHB(OAc)3 (0.094g, 0.44 mmol). The resulting solution was stirred at rt for 24h. DCM was added and the organic layer washed with saturated Na2CO3 solution, brine, dried (MgSO4) and the solvent removed in vacuo. The crude material was purified by flash chromatography with EtOAc as eluent to afford the title compound (0.098g, 70%): RT = 2.56 min; m/z (ES+) = 409.3 [M+ H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 4 A molecular sieve In dichloromethane at 20℃; for 3h; | 83 Example 83; 4-{2-[4-(6-Methanesulfonylpyridin-3-yl)piperazin-l-yl]ethyl}piperidine-l- carboxylic acid terf-butyl ester; A solution of 4-(6-methanesulfonylpyridin-3-yl)piperazine-l-carboxylic acid tert-butyl ester (0.14g, 0.4 mmol) in DCM (1OmL) was treated with TFA (ImL) and the mixture stirred at rt for 3h. DCM (3OmL) was added and the organic layer washed with IM NaOH solution, brine, dried (MgSO4) and the solvent removed in vacuo to yield l-(6-methanesulfonylpyridin-3- yl)piperazine as a yellow solid (0.095g, 100%). The solid was dissolved in DCM (8mL) and treated with N-boc-piperidinyl-4-acetaldehyde (0.088g, 0.39 mmol) and 4A molecular sieves (O.lg) at room temperature. The solution was allowed to stir for 3h then treated with NaHB(OAc)3 (0.106g, 0.5 mmol). The resulting solution was stirred at rt for 2Oh. DCM (2OmL) was added and the organic layer washed with saturated Na2CO3 solution, brine, dried (MgSO4) and the solvent removed in vacuo. The crude material was purified by flash chromatography with EtOAc as eluent to afford the title compound (O.lOlg, 58%): RT = 2.61 min; m/z (ES+) = 453.4 [M+ H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 4 A molecular sieve In tetrahydrofuran; dichloromethane at 20℃; for 1h; | 84 Example 84; 4-{2-[4-(5-Methanesulfonylpyridin-2-yl)piperazin-l-yl]ethyl}piperidine-l- carboxylic acid tert-butyl ester; A solution of 4-(5-methanesulfonylpyridin-2-yl)piperazine-l-carboxylic acid tert-butyl ester (0.075g, 0.23 mmol) in DCM (5mL) was treated with TFA (0.5mL) and the mixture stirred at rt for 4h. DCM (3OmL) was added and the organic layer washed with IM NaOH solution, brine, dried (MgSO4) and the solvent removed in vacuo to yield l-(5-methanesulfonylpyridin-2- yl)piperazine as a white solid (0.07g, 100%). The solid (0.064g, 0.27mmol) was dissolved in 1:1 DCM/THF (12mL) and treated with N-boc-piperidinyl-4-acetaldehyde (0.061g, 0.27 mmol) and 4A molecular sieves (O.lg) at rt. The solution was allowed to stir for Ih then treated with NaHB(OAc)3 (0.074g, 0.35 mmol). The resulting solution was stirred at rt for 24h. DCM (3OmL) was added and the organic layer washed with saturated Na2CO3 solution, brine, dried (MgSO4) and the solvent removed in vacuo. The crude product was triturated with Et2O, filtered EPO and dried in vacuo to afford the title compound (0.043g, 35%): RT = 2.49 min; m/z (ES+) = 453.4 [M+ H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With ammonium cerium(IV) nitrate; water; sodium hydrogencarbonate In 1,2-dimethoxyethane at -50℃; for 24h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N,N,N',N'-tetramethylguanidine In tetrahydrofuran at -78 - 20℃; for 2h; | 1.c 1-D: To a solution of Cbz-?-phosphonoglycine trimethyl ester (2.8 g, 8.45 mmol) in THF at -78 C. is added 1,1,3,3-tetramethyl-guanidine (1.022 ml, 8.14 mmol). After 10 minutes, the aldehyde 1-C (1.76 g, 7.76 mmol) is added. The solution is then placed in an ice bath at 0 C. for 1 hour, and then allowed to warm to room temperature and stirred for one more hour. The solution is diluted with EtOAc, washed with 1M NaHSO4, dried (MgSO4) and concentrated in vacuo. The residue is purified by silica gel flash chromatography with Ethyl acetate/Hexane 0 to 100% to afford 1-D as a white solid. MS m/z 333.2 (M+1), 1H NMR (CDCl3, 400 MHz) ?. 7.35-7.33 (5H, m), 6.63 (1H, t, J=8 Hz), 6.30 (1H, bs), 5.12 (2H, s), 4.10-4.04 (2H, m), 3.73 (3H, s), 2.67-2.62 (2H, m), 2.14 (2H, t, J=6.8 Hz), 1.63-1.46 (3H, m), 1.43 (9H, s), 1.14-1.06 (2H, m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: trimethyl phosphonoacetate With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.333333h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at -78℃; for 0.75h; Stage #3: With triethylamine more than 3 stages; | 14 Example 14; [1- [1-OXO-3- (5,] 6,7, [8-TETRAHYDRO-1,] 8-naphthyridin-2-yl) [PROPYL]-D-PHENYL-4-] piperidinebutanoic acid (Cpd 13) Di-tert-butyl dicarbonate (41.25g, 189 mmol) was added in one portion to a solution of 4- (2-hydroxyethyl) piperidine Compound 14a (24.42g, 189 mmol) in DMF (200 mL) at [0 °C.] After 1 hour, the cooling bath was removed and the reaction mixture was allowed to stir for 20 h at RT. The reaction mixture was treated with Et2O (200 [ML)] and [H20] (500 mL). The organic layer was separated, washed with sat NH4C1 (200 mL) and brine (200 mL) and dried [MGS04).] After filtration and evaporation, Compound 14b was obtained as a transparent oil and used as such without further purification. A solution of DMSO (14g, 179 mmol) in DCM (80 mL) was added dropwise over a period of 1.5 h to a 2M solution of oxalyl chloride (62.8mL, 125.6 mmol) in dry DCM (200 mL) [AT-78 °C,] such that the temperature did not [EXCEED-60 °C.] A solution of Compound 14a in DCM (30 mL) was added dropwise at-78°C over a 50 min period. After stirring 30 min [AT-78 °C,] the cooling bath was removed and the temperature of the reaction mixture was allowed to rise to-30 °C over a 30 min period. TEA (25.41 g, 251 mmol) was added and the reaction mixture was allowed to stir for lh at rt. The solid precipitate that had formed was removed by filtration and the filtrate was washed with 0.3N [HC1] (2 x [100] mL) and brine (200 mL). The organic phase was dried [(NA2SO4),] evaporated and the residue was purified via flash column chromatography (eluent gradient : hexane/EtOAc 100/0 to 70/30) to yield Compound 14c. A 1M solution [OF LIHMDS] (73 mL, 73 mmol) was added via syringe to a solution of trimethyl phosphonoacetate (13.29g, 73 mmol) in THF (200 mL) at-78°C under argon. The reaction mixture was then stirred for 20 min at-78°C and a solution of Compound 14c (8.3g, 36.5 mmol) in THF (50 mL) was added over a 30 min period. After stirring for 15 min [AT-78 °C,] the cooling bath was removed and the reaction mixture was heated to reflux for 2. The reaction mixture was allowed to cool to room temperature and a saturated [NH4CL] solution (40 mL) was added. [ET20] (200 mL) was added, the organic layer was separated and washed with brine (140 mL) and dried [(NA2S04).] After filtration and evaporation, the residue was purified via flash column chromatography (eluent gradient : hexane/EtOAc: 100/0 to 85/15), yielding a mixture of [E-AND] Z- isomers of Compound 14d. Compound 14d, phenyl boronic acid [(1.] [55G,] 12.32 mmol), [RhCl (Cod) ] 2 [(0.] [LU ; 0.] 227 mmol) and Cod (0.557g, 5.15 mmol) were combined in [H20] [(15ML)] and heated to 100 [°C] for 3 h under a nitrogen atmosphere. Phenylboronic acid [(L.] [OG,] 8. 2 mmol) was added again and the reaction mixture was heated to [100 °C] for another 6 h. The reaction mixture was allowed to cool to rt, Et20 (100 mL) was added and the organic layer was separated. The aqueous layer was washed with [ET20] (2 x 100 mL) and the combined organic layers were dried [(NA2SO4),] filtered and evaporated. The residue was purified via flash column chromatography, yielding Compound 14e. TFA (6 mL) was added to a solution of Compound 14e (1.48 g, 4.09 mmol) in DCM (14 mL). The mixture was stirred at rt for 20 min, concentrated under vacuum and purified via RP-HPLC to yield Compound 14f as a trifluoroacetate salt. HOBt (0.333 g, 2.46 mmol), EDC (0.47 g, 2.46 mmol) and NMM (0.68 g, 5.28 mmol) were added to a solution of Compound 8a [(0. 64] g, 2.64 mmol) in DMF (30 mL) under argon. The mixture was stirred at rt for 1 h, then a solution of Compound 14f (0.66 g, 1.76 mmol) and NMM (0. [68] g, 5.28 mmol) in DMF (10 mL) was added. The resulting mixture was stirred overnight at rt. Water (2 mL) was added, followed by DCM (20 mL). The organic layer was separated, dried [(NA2SO4)] and concentrated. The resulting crude Compound 14g was used as such in the next reaction. To a solution of Compound 14g in dioxane (2 mL) and [H20] [(1] mL) was added [NAOH] (0.78g, 19. 5 mmol). The mixture was stirred at rt for 5 h and neutralized with 2N HCI. After the solvent was evaporated, the residue was purified by RP-HPLC to give Compound 13 after lyophilization |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: N-(benzyloxycarbonyl)phosphonoglycine trimethyl ester With N,N,N',N'-tetramethylguanidine In tetrahydrofuran at -78℃; for 0.166667h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at 0 - 20℃; for 2h; | c To a solution of Cbz-α-phosphonoglycine trimethyl ester, (2.8g, 8.45 mmol) in THF at -78 0C is added 1,1,3,3-tetramethyl-guanidine (1.022 ml, 8.14 mmol). After 10 minutes, the aldehyde 3 (1.76g, 7.76 mmol) is added. The solution is then placed in an ice bath at 00C for 1 hour, warmed to room temperature and stirred for one more hour. The solution is diluted with EtOAc, washed with IM NaHSO4, dried (MgSO4) and concentrated in vacuo. The residue is purified by chromatography (ISCO) with Ethyl acetate/Hexane 0 to 100% to afford 4-D as a white solid. MS m/z 333.2 (M + 1), 1H NMR (CDC13, 400 MHz) δ. 7.35-7.33 (5H, m), 6.63 (IH, t, J = 8 Hz), 6.30 (IH, bs), 5.12 (2H, s), 4.10-4.04 (2H, m), 3.73 (3H, s), 2.67-2.62 (2H, m), 2.14 (2H, t, J = 6.8 Hz), 1.63-1.46 (3H, m), 1.43 (9H, s), 1.14-1.06 (2H, m). | |
Stage #1: N-(benzyloxycarbonyl)phosphonoglycine trimethyl ester With N,N,N',N'-tetramethylguanidine In tetrahydrofuran at -78℃; for 0.166667h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at 0 - 20℃; for 2h; | c To a solution of Cbz-α-phosphonoglycine trimethyl ester, (2.8g, 8.45 mmol) in THF at -78 0C is added 1,1,3,3-tetramethyl-guanidine (1.022 ml, 8.14 mmol). After 10 minutes, the aldehyde 8-C (1.76g, 7.76 mmol) is added. The solution is then placed in an ice bath at 00C for 1 hour, and then allowed to warm to room temperature and stirred one more hour. The solution is diluted with EtOAc, washed with IM NaHSO4, dried (MgSO4) and concentrated in vacuo. The residue is purified by automated silica gel chromatography with EtOAc/hexanes (0-100%) to afford 8-D as a clear oil. MS m/z 333.2 (M + 1), 1H NMR (CDC13, 400 MHz) δ. 7.35-7.33 (5H, m), 6.63 (IH, t, J = 8 Hz), 6.30 (IH, bs), 5.12 (2H, s), 4.10-4.04 (2H, m), 3.73 (3H, s), 2.67-2.62 (2H, m), 2.14 (2H, t, J = 6.8 Hz), 1.63-1.46 (3H, m), 1.43 (9H, s), 1.14-1.06 (2H, m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: diethyl 1-cyanomethylphosphonate With potassium <i>tert</i>-butylate In tetrahydrofuran at 0 - 30℃; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at 0 - 30℃; | 1.2 To a solution of 1.0 M of potassium tert-butoxide in tetrahydrofuran (45.8 mL) at 0 0C was added dropwise a solution of diethyl cyanomethylphosphonate (7.77 mL, 0.0480 mol) in tetrahydrofuran (58.39 mL). The reaction was warmed to room temperature and then cooled at 0 0C again. To the reaction mixture was added a solution of tert-butyl 4-(2-oxoethyl)piperidine- 1 -carboxylate (9.91 g, 0.0436 mol) in tetrahydrofuran (11.7 mL). The reaction was allowed to warm up to room temperature and stirred at room temperature overnight. After being quenched with water, the mixture was extracted with EtOAc. The combined organic layers were washed with brine, dried and evaporated to dryness. The crude mixture was purified on silica gel, eluting with 0 to 40% EtOAc in hexanes, to give the desired product (8.22 g, 75% in 2 steps). LCMS (M+Na) 273.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | In ethanol for 72h; Heating / reflux; | 22 Example 22; tert-Butyl 4-[(1-methyl-7-methyl-1H-benzimidazol-2-yl)methyl]piperidine-1-carboxylate; 3,N-2-Dimethyl-benzene-1,2-diamine (204.3 mg, 1.5 mmol) was dissolved in ethanol (10 mL). Palladium on carbon (100 mg) was added follow by 4-(2-Oxo-ethyl)-piperidine-1-carboxylic acid tert-butyl ester (376 mg, 1.65 mmol). The reaction mixture was refluxed for 3 days. The reaction was then filtered through diatomaceous earth pad and the filtrate was concentrated in vacuo. The crude residue was purified on silica gel using ethyl acetate:hexane=40%:60%, then 2M ammonia in methanol:ethyl acetate=5%:95% to give the product as yellow gum (330 mg, 64%).1HNMR (300 MHz, CDCl3): (ppm) 7.57 (d, 1H), 7.11 (t, 1H), 6.97 (d, 1H), 3.98 (s, 3H), 2.82 (d, 2H), 2.8 (s, 3H), 2.76 (br, 2H), 2.06 (br, 1H), 1.7 (br, 4H), 1.46 (s, 9H), 1.28 (br, 2H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Under cooling at -78C, a solution of 1.50 g of 4-bromo-2,6-dimethylanisole in 20 ml of tetrahydrofuran was added to a solution of 1.6M hexane solution of 4.8 ml of n-butyl lithium in 20 ml of tetrahydrofuran. The mixture was stirred for 1 hour. A solution of 1.50 g of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate in 20 ml of tetrahydrofuran was added to the mixture. After stirring for 30 minutes, the mixture was stirred at ambient temperature for further 3 hours. The reaction mixture was poured into water, followed by extraction with ethyl acetate. The organic layer was washed with saturated aqueous sodium chloride and then dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated and the resulting residue was purified by silica gel column chromatography (hexane-ethyl acetate) to give 628 mg of tert-butyl 4-[2-hydroxy-2-(4-methoxy-2,6-dimethylphenyl)ethyl]piperidine-1-carboxylate as an oil. To the oil was added 15 ml of 10% hydrochloric acid and the mixture was heated under reflux for 2 hours. After cooling, the reaction mixture was alkalized with 20% aqueous sodium hydroxide solution,, followed by extraction with ethyl acetate. The organic layer was washed with saturated aqueous sodium chloride and then dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure to give 291 mg of tert-butyl 4-[(E)-2-(4-methoxy-2,6-dimethylphenyl)vinyl]piperidine-1-carboxylate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | In tetrahydrofuran; toluene at 20℃; for 2h; | 13 5.1.13 tert-Butyl 4-(2-hydroxypropyl)piperidine-1-carboxylate (15b) To a solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (15a, 250mg, 1.10mmol) in THF (5mL) was added 1.4M methyl magnesium bromide in toluene-THF (1.2mL, 1.68mmol), followed by stirring at room temperature for 2h. Water was added to the reaction liquid, followed by extraction with ethyl acetate. The organic layer was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography [chloroform/methanol=1:0-10:1] to give 15b (236mg, 88%) as a colorless oily substance. 1H NMR-CDCl3 (400MHz) δ 0.99-1.78 (20H, m), 2.70 (2H, m), 3.93 (1H, m), 4.08 (2H, m). FAB-MS: m/z 244 [M+H]+. |
Stage #1: methylmagnesium bromide; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran; water; toluene at 20℃; Stage #2: With water In tetrahydrofuran; toluene | 5 Production Example 5 To a solution of 250 mg of tert-butyl 4-(2-oxoethyl) piperidine-1-carboxylate in 5 mL of THF was added 1.2 mL of 1.4M methyl magnesium bromide in toluene-THF, followed by stirring at room temperature for 2 hours. Water was added to the reaction liquid, followed by extraction with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography [chloroform:methanol = 1:0-10:1] to obtain 236 mg of tert-butyl 4-(2-hydroxypropyl)piperidine-1-carboxylate as a colorless oily substance. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | With sodium tris(acetoxy)borohydride; acetic acid In 1,2-dichloro-ethane at 20℃; | 53.1 Example 53- Preparation of Compound No. 1.501; (l) To a mixture of l-methyl-2-(piperidin-4-yloxy)-lH-[4,4']bipyrimidinyl- 6-one (290 mg, 1.0 mmo, terthntyl 4-(2-oxo-ethyl)piperidine-l-carboxylate (300 mg 1.3 mmol) and acetic acid (one drop) in 1,2-dichloroethane (5.0 ml) was added sodiumtriacetoxyborohydride (530 mg, 2.5 mmol). The mixture was stirred at room temperature overnight. The mixture was partitioned between water and dichloromethane. The organic layer was washed with brine, dried over sodium sulfate, and concentrated in vacuo. The residue was purified by NH-silica gel column chromatography (eluent. hexane/ethyl acetate = 30/70) to afford terthutyλ 4-{2-[4-(l-methyl-6-oxo-l,6-dihydro-[4,4']bipyrimidinyl-2-yloxy)piperidin-l-yl]ethyl}piperidine-l-car boxylate as a colorless solid (340 mg, 0.67 mmol, 67%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (5S)-5-benzyl-2,2,3-trimethylimidazolidin-4-one; N-fluorobis(benzenesulfon)imide In tetrahydrofuran; isopropyl alcohol at -15℃; | ||
With (R)-5-benzyl-2,2,3,-trimethylimidazolidin-4-one dichloroacetic acid salt; N-fluorobis(benzenesulfon)imide In tetrahydrofuran; isopropyl alcohol at -20 - 10℃; for 16h; | 1 Step 1: (S)-tert-butyl 4-(1-fluoro-2-oxoethyl)piperidine-1-carboxylate To a suspension of N-fluoro-N-(phenylsulfonyl)benzenesulfonamide ((CAS 133745-75-2, 347 g, 1100 mmol) and (5R)-(+)-2,2,3-trimethyl-5-benzyl-4-imidazolidinone dichloroacetic acid (CAS 857303-87-8, 76 g, 220 mmol) in THF and isopropyl alcohol at -20 °C was added a solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (250 g, 1100 mmol, CAS: 142374-19-4) in THF. The mixture was stirred at 10 °C for 16 h, diluted with hexane at -78 °C and filtered through silica, washed with hexane, then with saturated aqueous NaHCO3, dried, filtered, and concentrated to give (S)-tert-butyl 4-(1-fluoro-2-oxoethyl)piperidine-1- carboxylate. | |
With (5R)-(+)-2,2,3-trimethyl-5-benzyl-4-imidazolidinone dichloroacetic acid; N-fluorobis(benzenesulfon)imide In tetrahydrofuran; isopropyl alcohol at -20 - 10℃; for 6h; | 1 Step 1: (S)-tert-butyl 4-(1-fluoro-2-oxoethyl)piperidine-1-carboxylate To a suspension of N-fluoro-N-(phenyl sulfonyl)benzenesulfonamide ((CAS 133745-75-2, 347 g, 1100 mmol) and (5R)-(+)-2,2,3-trimethyl-5-benzyl-4-imidazolidinone dichloroacetic acid (CAS 857303-87-8, 76 g, 220 mmol) in THF and isopropyl alcohol at -20° C. was added a solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (250 g, 1100 mmol, CAS: 142374-19-4) in THF. The mixture was stirred at 10° C. for 16 h, diluted with hexane at -78° C. and filtered through silica, washed with hexane, then with saturated aqueous NaHCO3 solution, dried, filtered, and concentrated to give (S)-tert-butyl 4-(1-fluoro-2-oxoethyl)piperidine-1-carboxylate. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75.3% | Stage #1: diethyl 1-cyanomethylphosphonate With potassium <i>tert</i>-butylate In tetrahydrofuran at 0 - 20℃; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at 0 - 20℃; | 5.2 To a solution of 1.0 M of potassium tert-butoxide in THF (45.8 mL, 0.0458 mol) at 0 °C was added dropwise a solution of diethyl cyanomethylphosphonate (7.8 mL, 0.0480 mol) in THF (58.4 mL). The reaction was warmed to RT and then cooled to 0 °C again. To the reaction mixture was added a solution of tert-butyl 4-(2-oxoethyl)piperidine-l-carboxylate (9.91 g, 0.0436 mol) in THF (11.7 mL). The reaction was allowed to warm up to RT and stirred at RT overnight. After being quenched with water, the mixture was extracted with EtOAc. The combined organic layers were washed with brine, dried and evaporated to dryness. The crude mixture was purified on silica gel, eluting with 0 to 40% EtOAc in hexanes, to provide the desired product (8.22 g, 75.3%). LCMS calculated forCi4H22N202Na(M+Na)+: m/z = 273.2; Found: 273.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With potassium carbonate In methanol at 0 - 25℃; for 16h; Inert atmosphere; | Tert-butyl 4-prop-2-ynylpiperidine-1-carboxylate (Intermediate AKO) To a solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (500 mg, 2.20 mmol, CAS 142374-19-4), K2CO3(912 mg, 6.60 mmol) in MeOH (15 mL) was added 1-diazo- 1-dimethoxyphosphoryl-propan-2-one (507 mg, 2.64 mmol, CAS 90965-06-3) at 0 °C. The mixture was stirred at 25 °C for 16 hours. On completion, the mixture was concentrated in vauco. The mixture was diluted with H2O (30 mL), then extracted with EA (3 X 20 mL). The organic layers were washed with brine (2 X 15 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo to give the title compound (490 mg, 99% yield) as yellow oil.1H NMR (400MHz, CDCl3) d 4.25 - 4.03 (m, 2H), 2.78 - 2.65 (m, 2H), 2.22 - 2.13 (m, 2H), 2.00 (t, J = 2.8 Hz, 1H), 1.85 - 1.72 (m, 2H), 1.72 - 1.60 (m, 1H), 1.48 (s, 9H), 1.30 - 1.15 (m, 2H). |
99% | With potassium carbonate In methanol at 0 - 25℃; for 16h; Inert atmosphere; | Tert-butyl 4-prop-2-ynylpiperidine-1-carboxylate (Intermediate AKO) To a solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (500 mg, 2.20 mmol, CAS 142374-19-4), K2CO3 (912 mg, 6.60 mmol) in MeOH (15 mL) was added 1-diazo- 1-dimethoxyphosphoryl-propan-2-one (507 mg, 2.64 mmol, CAS 90965-06-3) at 0 °C. The mixture was stirred at 25 °C for 16 hours. On completion, the mixture was concentrated in vauco. The mixture was diluted with H2O (30 mL), then extracted with EA (3 X 20 mL). The organic layers were washed with brine (2 X 15 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo to give the title compound (490 mg, 99% yield) as yellow oil. 1H NMR (400MHz, CDCl3) d 4.25 - 4.03 (m, 2H), 2.78 - 2.65 (m, 2H), 2.22 - 2.13 (m, 2H), 2.00 (t, J = 2.8 Hz, 1H), 1.85 - 1.72 (m, 2H), 1.72 - 1.60 (m, 1H), 1.48 (s, 9H), 1.30 - 1.15 (m, 2H). |
99% | With potassium carbonate In methanol at 0 - 25℃; for 16h; Inert atmosphere; | Tert-butyl 4-prop-2-ynylpiperidine-1-carboxylate (Intermediate AKO) To a solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (500 mg, 2.20 mmol, CAS 142374-19-4), K2CO3 (912 mg, 6.60 mmol) in MeOH (15 mL) was added 1-diazo-1-dimethoxyphosphoryl- propan-2-one (507 mg, 2.64 mmol, CAS 90965-06-3) at 0 °C. The mixture was stirred at 25 °C for 16 hours. On completion, the mixture was concentrated in vauco. The mixture was diluted with H2O (30 mL), then extracted with EA (3 X 20 mL). The organic layers were washed with brine (2 X 15 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo to give the title compound (490 mg, 99% yield) as yellow oil.1H NMR (400MHz, CDCl3) δ 4.25 - 4.03 (m, 2H), 2.78 - 2.65 (m, 2H), 2.22 - 2.13 (m, 2H), 2.00 (t, J = 2.8 Hz, 1H), 1.85 - 1.72 (m, 2H), 1.72 - 1.60 (m, 1H), 1.48 (s, 9H), 1.30 - 1.15 (m, 2H). |
67% | With potassium carbonate In methanol at 20℃; | B58.1 (a) Step 1 A solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (0.596 g, 2.62 mmol) in methanol (10 mL) was added with potassium carbonate (0.724 g, 5.24 mmol), and the mixture was stirred at room temperature. The reaction mixture was added with dimethyl (1-diazo-2-oxopropyl)phosphonate (0.500 g, 2.62 mmol), and the mixture was stirred at room temperature for additional 4 hours. The reaction mixture was concentrated, and then added with water, and the mixture was extracted with methylene chloride. The organic layer was washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated, and the resulting residue was purified by silica gel column chromatography (hexane/ethyl acetate) to obtain tert-butyl 4-(prop-2-ynyl)piperidine-1-carboxylate (0.393 g, 67%). 1H NMR (300 MHz, CDCl3) δ 1.13-1.27 (m, 2H), 1.54 (s, 9H), 1.56-1.70 (m, 1H), 1.74-1.78 (m, 2H), 1.98 (t, J = 2.9 Hz, 1H), 2.15 (dd, J = 6.6 Hz, 2.9 Hz, 2H), 2.65-2.73 (m, 2H), 4.09-4.13 (m, 2H). |
34% | With potassium carbonate In methanol at 20℃; for 3h; | Step 1:tert-butyl 4-(prop-2-yn-1-yl)piperidine-1-carboxylate. Add dimethyl1-diazo-2-oxopropylphosphonate (507 mg, 2.64 mmol) in methanol (10 mL) dropwiseat room temperature to a stirred mixture of tert-butyl4-(2-oxoethyl)piperidine-1-carboxylate (300 mg, 1.32 mmol) and potassiumcarbonate (364 mg, 2.64 mmol) in methanol (15 mL). The resulting mxiture was stirred at room temperaturefor 3 hours. The reaction was concentrated and the residue was dissolved inether (10 mL) and washed with saturated aqueous sodium bicarbonate solution (10mL). The aqueous phase was extracted with ether (2x10 mL), and the combinedorganic phase was dried over sodium sulfate, filtered, and concentrated todryness. The crude material waspurified by silica gel chromatography (12 g) eluting with ethyl acetate inpetroleum ether from 0 to 30% over 20 minutes to afford tert-butyl4-(prop-2-yn-1-yl)piperidine-1-carboxylate (100 mg, yield: 34%) as a colorlessoil. MS (M+Na)+ = 246.2 |
294 mg | With potassium carbonate In methanol at 20℃; for 17h; | Intermediate 7: fe/f-Butyl 4-(prop-2-yn-l-yl)piperidine-l-carboxylate Intermediate 7: fe/f-Butyl 4-(prop-2-yn-l-yl)piperidine-l-carboxylate To a solution of fe/ -butyl 4-(2-oxoethyl)piperidine-l-carboxylate (383 mg, 1.685 mmol) in anhydrous methanol (6 mL) was added potassium carbonate (466 mg, 3.37 mmol) and the suspension was stirred at room temperature for 5 minutes. Dimethyl (l-diazo-2- oxopropyl)phosphonate (388 mg, 2.022 mmol) was then added and the reaction was stirred at room temperature for 17 hours. The reaction was partitioned between diethyl ether and saturated aqueous sodium hydrogencarbonate solution. The organic phase was separated, passed through a hydrophobic frit and evaporated in vacuo to yield a yellow oil. The crude material was loaded onto a lOg isolute silica cartridge in the minimum volume of ethyl acetate and eluted with ethyl acetate (40 mL). The ethyl acetate eluent was evaporated in vacuo to yield the title compound as a colourless oil (294 mg). Η NMR (400 MHz, CDCI3) δ ppm 4.00 - 4.20 (m, 2 H) 2.61 - 2.78 (m, 2 H) 2.10 - 2.20 (m, 2 H) 1.93 - 2.01 (m, 1 H) 1.56 - 1.81 (m, 4 H) 1.46 (s, 9 H) 1.11 - 1.29 (m, 2 H) |
Stage #1: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With potassium carbonate In methanol at 20℃; for 0.0833333h; Stage #2: dimethyl 1-(1-diazo-2-oxopropyl)phosphonate In methanol at 20℃; for 17h; | C Step C: synthesis of 3-(1-tert-butoxycarbonyl-4-piperidyl)propyne 2-(1-Tert-butoxycarbonyl-4-piperidyl)acetaldehyde (4.85 g, 21.34 mmol) was dissolved in 50 mL methanol, potassium carbonate (5.90 g, 42.68 mmol) was added. After the mixture was stirred at room temperatrue for 5 minutes, dimethyl (1-diazo-2-oxopropyl) phosphonate (4.10 g, 21.34 mmol) was added dropwise. After the addition, the reaction mixture was stirred for 17 h at room temperature, and then poured into the mixture of dichloromethane (250 mL) and saturated aqueous solution of sodium bicarbonate (50 mL). The organic layer was separated and filtered through celite pad. The filtrate was concentrated under vacuum. The residue was dissolved in ethyl acetate (50 mL) and filtered through silica gel pad. The filter cake was washed with ethyl acetate (30 mL×3). The combined filtrate was concentrated under vacuum to afford 3-(1-tert-butoxy carbonyl-4-piperidyl)propyne (3.92 g). 1H NMR (400 MHz, CHLOROFORM-d) δ 4.12 (d, J=3.5 Hz, 2H), 2.69 (t, J=11.8 Hz, 2H), 2.15 (dd, J=2.6, 6.7 Hz, 2H), 1.99 (t, J=2.6 Hz, 1H), 1.76 (d, J=13.3 Hz, 3H), 1.46 (s, 9H), 1.20 (dq, J=4.4, 12.3 Hz, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | Stage #1: (5-fluoro-pyridin-2-yl)-hydrazine; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In ethanol at 0℃; for 0.5h; Reflux; Stage #2: With [bis(acetoxy)iodo]benzene In ethanol; dichloromethane at 20℃; for 0.516667h; | 22.a a. 4-(6-Fluoro-[l,2,4]triazolo[4,3-a]pyridin-3-ylmethyl)-piperidine-l- carbo ter (Intermediate 22 a) a. 4-(6-Fluoro-[l,2,4]triazolo[4,3-a]pyridin-3-ylmethyl)-piperidine-l- carbo ter (Intermediate 22 a) A dark brown solution of (5-fluoro-pyridin-2-yl)-hydrazine (549 mg, 4.32 mmol) and N-Boc-4-piperidine acetaldehyde (Aldrich, 982 mg, 4.32 mmol) in EtOH (10 mL) was stirred at reflux for 30 min, then cooled to 0°C, diluted with DCM (25 mL) and then (diacetoxyiodo)benzene (1.67 g, 5.18 mmol) was added portionwise over 1 min. The purple solution was stirred at RT for 30 min, then aqueous NaOH (1M, 20 mL) was added and the mixture shaken. The aqueous layer was extracted with DCM (2 20 mL), then the combined organics passed through a hydrophobic frit and concentrated in vacuo to leave an orange solid. FCC, using 3% MeOH in DCM, gave the title compound as a pale orange solid (1.53 g, 90%). LCMS (Method 3): Rt 3.15, m/z 235 [M-CO2C4H9+H+]. |
90% | Stage #1: (5-fluoro-pyridin-2-yl)-hydrazine; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In ethanol for 0.5h; Reflux; Stage #2: With [bis(acetoxy)iodo]benzene at 0 - 20℃; for 0.5h; | 22.a a.4-(6-Fluoro-[1,2,4]triazolo[4,3-a]pyridin-3-ylmethyl)-piperidine-1-carboxylic acid tert-butyl ester (Intermediate 22a) a. 4-(6-Fluoro-[1,2,4]triazolo[4,3-a]pyridin-3-ylmethyl)-piperidine-1-carboxylic acid tert-butyl ester (Intermediate 22a) A dark brown solution of (5-fluoro-pyridin-2-yl)-hydrazine (549 mg, 4.32 mmol) and N-Boc-4-piperidine acetaldehyde (Aldrich, 982 mg, 4.32 mmol) in EtOH (10 mL) was stirred at reflux for 30 min, then cooled to 0° C., diluted with DCM (25 mL) and then (diacetoxyiodo)benzene (1.67 g, 5.18 mmol) was added portionwise over 1 min. The purple solution was stirred at RT for 30 min, then aqueous NaOH (1M, 20 mL) was added and the mixture shaken. The aqueous layer was extracted with DCM (2*20 mL), then the combined organics passed through a hydrophobic frit and concentrated in vacuo to leave an orange solid. FCC, using 3% MeOH in DCM, gave the title compound as a pale orange solid (1.53 g, 90%). LCMS (Method 3): Rt 3.15, m/z 235 [M-CO2C4H9+H+]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With pyrrolidine; p-N,N-dimethylaminobenzoic acid In dichloromethane; water for 6h; Reflux; | tert-butyl 4-(3-oxoprop-1-en-2-yl)piperidine-1-carboxylate Prepared using the α-methylenation procedure A described by Erkkilä and Pihko2 using aldehyde S3 (600 mg, 2.64 mmol, 1.0 equiv), formaldehyde (37 % formaldehyde inwater, 79 mg, 197 L, 2.64 mmol, 1.0 equiv), pyrrolidine (19 mg, 22 μL, 0.26 mmol, 0.1equiv), p-dimethylaminobenzoic acid (87 mg, 0.53 mmol, 0.2 equiv) and DCM (10 mL).Crude product was purified by flash chromatography (silica gel, n-hexane/EtOAc 80:20)to afford product 1h as a colorless oil (545 mg, 2.28 mmol, 86 %). |
With pyrrolidine; p-N,N-dimethylaminobenzoic acid In dichloromethane Reflux; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | With methanol; potassium carbonate In acetonitrile at 20℃; for 17h; | 30.2 Example 30: Synthesis of (2S,5R)-7-oxo-2-(5-(piperidin-4-ylmethyl)isoxazol-3-yl)-l ,6- diazabicyclo[3.2.1 loctan-6-yl hydrogen sulfate (Compound 627) Example 30: Synthesis of (2S,5R)-7-oxo-2-(5-(piperidin-4-ylmethyl)isoxazol-3-yl)-l ,6- diazabicyclo[3.2.1 loctan-6-yl hydrogen sulfate (Compound 627) Synthetic scheme: Characterization: (2S,5R)-7-oxo-2-(5-(piperidin-4-ylmethyl)isoxazol-3-yl)-l,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate (627, 31 mg) was obtained as a white solid after prep-HPLC purification using ammonium formate buffer. ESI-MS (EI+, m/z): 387.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With pyridine; diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; at 100℃; for 5h; | To a solution of <strong>[54675-23-9]6-bromo-4-hydroxyquinolin-2(1H)-one</strong> (1.05 g, 4.37 mmol, Intermediate 38: step b) and tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (0.99 g, 4.37 mmol) in pyridine (7.9 mL) was added diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylate (1.11 g, 4.37 mmol) and the resulting suspension heated to 100 C. for 5 hours. The mixture was cooled to room temperature and diluted with Et2O. The ether was decanted and the residue then concentrated to dryness to afford a solid. Diethyl ether was added and the resulting suspension filtered. The solids were dried to provide the title compound. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | Stage #1: (trifluoromethyl)trimethylsilane; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With tetrabutyl ammonium fluoride In tetrahydrofuran at 0 - 20℃; for 1h; Stage #2: With hydrogenchloride In tetrahydrofuran; water at 20℃; for 2h; | 4 Step 4: tert-butyl 4-(3,3,3-trifluoro-2-hydroxy-propyl) piperidine-1-carboxylate To a mixture of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (1.9 g, 8.36 mmol, 1.0 eq) and trimethyl(trifluoromethyl)silane (1.43 g, 10.03 mmol, 1.2 eq) in tetrahydrofuran (20 mL) was added tetrabutylammonium fluoride (1 M, 0.1 mL) at 0° C. Then the mixture was stirred at 20° C. for 1 hour. Then aqueous hydrochloric acid (1 M, 17 mL, 2.0 eq) was added into the mixture and stirred at 20° C. for additional 2 hours. The mixture was extracted with dichloromethane (100 mL), washed with brine (50 mL), dried over anhydrous sodium sulfate and then concentrated. The residue was purified by silica column chromatography (petroleum ether:ethyl acetate=100:1 to 10:1) to afford tert-butyl 4-(3,3,3-trifluoro-2-hydroxy-propyl) piperidine-1-carboxylate (2.0 g, 6.73 mmol, 80% yield) as a white solid. |
80% | With tetrabutyl ammonium fluoride In tetrahydrofuran at 0 - 20℃; for 1h; | 4 Step 4: tert-butyl 4-(3,3,3-trifluoro-2-hydroxy-propyl) piperidine- 1-carboxylate To a mixture of tert-butyl 4-(2-oxoethyl)piperidine-l-carboxylate (1.9 g, 8.36 mmol, 1.0 eq) and trimethyl(trifluoromethyl)silane (1.43 g, 10.03 mmol, 1.2 eq) in tetrahydrofuran (20 mL) was added tetrabutylammonium fluoride (1 M, 0.1 mL) at 0 °C. Then the mixture was stirred at 20 °C for 1 hour. Then aqueous hydrochloric acid (1 M, 17 mL, 2.0 eq) was added into the mixture and stirred at 20 °C for additional 2 hours. The mixture was extracted withdichloromethane (100 mL), washed with brine (50 mL), dried over anhydrous sodium sulfate and then concentrated. The residue was purified by silica column chromatography (petroleum ether : ethyl acetate=100: l to 10: 1) to afford tert-butyl 4-(3,3,3-trifluoro-2-hydroxy-propyl) piperidine-1- carboxylate (2.0 g, 6.73 mmol, 80% yield) as a white solid. |
Stage #1: (trifluoromethyl)trimethylsilane; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With tetrabutyl ammonium fluoride In tetrahydrofuran at 0 - 20℃; for 1h; Stage #2: With hydrogenchloride In tetrahydrofuran; water at 20℃; for 2h; |
With tetrabutyl ammonium fluoride |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89 % ee | With 2,6-dimethylpyridine; (2R,5S)-2-tert-butyl-3,5-dimethylimidazolidin-4-one trifluoromethanesulfonate; [Fe(bpy)3]Br2 In N,N-dimethyl-formamide at 25℃; for 16h; Irradiation; Overall yield = 60 %; enantioselective reaction; | |
86 % ee | With 2,6-dimethylpyridine; C11H12ClNOPtS2; C14H20N2O In N,N-dimethyl-formamide at 20℃; Inert atmosphere; Irradiation; Overall yield = 47%; Overall yield = 18.1 mg; enantioselective reaction; | |
88 % ee | With 2,6-dimethylpyridine; (R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum(III) chloride; (2R,5S)-2-tert-butyl-3,5-dimethylimidazolidin-4-one trifluoromethanesulfonate In N,N-dimethyl-formamide at 20℃; for 18h; Inert atmosphere; Schlenk technique; Irradiation; Overall yield = 45 percent; Overall yield = 35 mg; enantioselective reaction; |
With 2,6-dimethylpyridine; C9H18N2O In N,N-dimethyl-formamide at -10℃; for 40h; Irradiation; Inert atmosphere; Overall yield = 55 percent; Optical yield = 85 percent ee; enantioselective reaction; | ||
78 % ee | With 2,6-dimethylpyridine; (2R,5S)-2-tert-butyl-3,5-dimethylimidazolidin-4-one trifluoromethanesulfonate In 1,2-dimethoxyethane at 20℃; for 46h; Inert atmosphere; Irradiation; Overall yield = 48 percent; enantioselective reaction; | 6 Example 6 In the reaction vessel, add 182 mg of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate, 68 μL of diethyl bromomalonate, and 91 μL of 2,6-lutidine , 0.2 equivalents of LZU-190, 0.25 equivalents of organic catalyst, 0.8 mL of DME, argon protection, visible light irradiation, stirring at room temperature for 46 hours, centrifugal washing and separation of LZU-190 after the reaction, spin-dry the supernatant, and use column chromatography The mixed solvent of petroleum ether and ethyl acetate with an elution liquid volume ratio of 50:1 has a yield of 48%, and the enantioselectivity is 78% measured with a high-performance liquid chromatograph |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | Stage #1: (S)-methyl 2-amino-3-hydroxypropanoate hydrochloride With triethylamine In dichloromethane for 0.25h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With potassium borohydride; magnesium sulfate In methanol at 0 - 20℃; for 4h; | 3.21 Preparation of (S)-tert-butyl 4-(2-((3-hydroxy-1-methoxy-1-oxopropan-2-yl)amino)ethyl)piperidine-1-carboxylate 5.33 g (34.3 mmol) of (S)-methyl 2-amino-3-hydroxypropanoate hydrochloride, 100 ml of dichloromethane and 4.78 ml (34.3 mmol) of triethylamine are introduced into a 250-ml flask. The mixture is stirred for 15 min, and then 7.79 g (34.3 mmol) of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate are added (prepared according to the method reported in Journal of Medicinal Chemistry, 2005, Vol. 48, No. 6, p 2100 2107) in solution in 10 ml of dichloromethane and 1.25 g of anhydrous MgSO4. After one night at room temperature, the medium is filtered and concentrated and then 70 ml of methanol and 1.85 g (34.3 mmol) of KBH4 are added at 0° C. At the end of 4 h, 100 ml of ethyl acetate are added and this is washed with 100 ml of water. After three extractions with ethyl acetate, the organic phases are collected, dried on Na2SO4, filtered and evaporated. 7.38 g (22.33 mmol) of (S)-tert-butyl 4-(2-((3-hydroxy-1-methoxy-1-oxopropan-2-yl)amino)ethyl)piperidine-1-carboxylate are obtained in the form of an orange oil, after purification by flash chromatography on silica gel (gradient; dichloromethane=100% to dichloromethane/(methanol:NH4OH 9:1)=95/5% over 30 min). Yield: 67% 1H NMR (CDCl3) δ: 1.11 (m, 2H); 1.45 (s, 9H); 1.48 (m, 3H); 1.63 (m, 2H); 2.00 (lm, 2H); 2.53 (m, 1H); 2.71 (m, 3H); 3.36 (dd, 1H, J=6.6 and 4.4 Hz); 3.57 (dd, 1H, J=10.6 and 6.8 Hz); 3.76 (s, 3H); 3.9 (m, 1H); 4.07 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | Preparation 61 tert-butyl 4-(2-[(4-bromopyridin-2-yl)methyl]amino}ethyl)piperidine-1-carboxylate To a solution of <strong>[865156-50-9](4-bromopyridin-2-yl)methanamine</strong> (2.86 g, 15.1 mmol) in methanol (75 mL) was added tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (3.44 g, 15.1 mmol). The reaction was stirred at room temperature for 18 hours and cooled to 0C in an ice bath. Sodium borohydride (173 g, 45.4 mmol) was added portionwise and after 30 minutes at room temperature, the mixture was quenched by addition of water (50 mL). The aqueous phase was extracted with ethyl acetate (3 x 100 mL) and the combined organic layers were washed with brine (100 mL), dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo to afford the title compound as a light yellow oil (5.76 g, 95%). (0920) 1 H NMR (400MHz, CDCI3): delta ppm 1 .05 (m, 2H), 1.40 (s, 9H), 1.50 (m, 2H), 1 .60 (m, 2H), 1 .70 (m, 1 H), 2.60 (m, 4H), 3.90 (s, 2H), 4.10 (br s, 2H), 7.30 (dd, 1 H), 7.50 (s, 1 H), 8.30 (d, 1 H). (0921) LCMS Rt = 1.91 minutes MS m/z 399 [M+H]+ | |
95% | To a solution of <strong>[865156-50-9](4-bromopyridin-2-yl)methanamine</strong> (2.86 g, 15.1 mmol) in methanol (75 mL) was added tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (3.44 g, 15.1 mmol). The reaction was stirred at room temperature for 18 h and cooled to 0 C in an ice bath. Sodium borohydride (1.73 g, 45.4 mmol) was added portion-wise, and after 30 min at rt the mixture was quenched by addition of water (50 mL). The aqueous phase was extracted with EtOAc (3 x 100 mL) and the combined organic layers were washed with brine (100 mL), dried over anhydrous magnesium sulfate, filtered and concentrated to afford product (5.76 g, 95%) as a light yellow oil. 1H NMR (400 MHz, CDCl3): delta 1.05 (m, 2H), 1.40 (s, 9H), 1.50 (m, 2H), 1.60 (m, 2H), 1.70 (m, 1H), 2.60 (m, 4H), 3.90 (s, 2H), 4.10 (br. s, 2H), 7.30 (dd, 1H), 7.50 (s, 1H), 8.30 (d, 1H); LCMS m/z 399 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | Stage #1: 4-({3-[2-(aminomethyl)pyridin-4-yl]-3'-(trifluoromethyl)biphenyl-4-yl}oxy)-5-chloro-2-fluoro-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide bisformate; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With triethylamine In methanol at 20℃; for 18h; Stage #2: With sodium tetrahydroborate In methanol at 20℃; for 0.5h; | 1 Preparation 1 tert-butyl 4-{2-[({4-[4-{2-chloro-5-fluoro-4-[(1,3,4-thiadiazol-2-ylamino)sulfonyl]phenoxy}-3'-(trifluoromethyl)biphenyl-3-yl]pyridin-2-yl}methyl)amino]ethyl}piperidine-1-carboxylate bis-formate salt Preparation 1 tert-butyl 4-{2-[({4-[4-{2-chloro-5-fluoro-4-[(1,3,4-thiadiazol-2-ylamino)sulfonyl]phenoxy}-3'-(trifluoromethyl)biphenyl-3-yl]pyridin-2-yl}methyl)amino]ethyl}piperidine-1-carboxylate bis-formate salt To a suspension of 4-({3-[2-(aminomethyl)pyridin-4-yl]-3'-(trifluoromethyl)biphenyl-4- yl}oxy)-5-chloro-2-fluoro-N-1 ,3,4-thiadiazol-2-ylbenzenesulfonamide bis-formate salt (Example 7, 50 mg, 0.069 mmol) in methanol (2 mL), was added triethylamine (30 μ, 0.207 mmol), followed by tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (23.4 mg, 0.103 mmol). The reaction was stirred at room temperature for 18 hours and sodium borohydride (16 mg, 0.414 mmol) was added. After 30 minutes at room temperature, the mixture was quenched by the addition of water (5 mL). The organic phase was extracted with ethyl acetate (3 x 5 mL) and the combined organic layers were washed with brine (10 mL), dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. The resulting residue was purified by reverse phase column chromatography eluting with 5-95% acetonitrile in water with 0.1 % formic acid) to afford the title compound (38 mg, 67%). 1 H NMR (400MHz, MeOD-d4): δ ppm 1.05 (m, 2H), 1.40 (s, 9H), 1.60-1.70 (m, 5H), 2.70 (m, 2H), 3.15 (d, 2H), 4.05 (d, 2H), 4.40 (s, 2H), 6.50 (d, 1 H), 7.30 (d, 1 H), 7.60-7.75 (m, 4H), 7.80 (m, 3H), 7.95 (m, 2H), 8.15 (br s, 1 H), 8.60 (m, 2H). 19F NMR (400MHz, MeOD d4): δ ppm -63.0 (s, 3F), -108.0 (s, 1 F). LCMS Rt = 2.67 minutes MS m/z 847 [M+H]+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | Stage #1: 4-({3-[2-(aminomethyl)pyridin-4-yl]-3'-(trifluoromethyl)biphenyl-4-yl}oxy)-3-cyano-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide bisformate; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With triethylamine In methanol at 20℃; for 18h; Stage #2: With sodium tetrahydroborate In methanol at 20℃; for 0.5h; | 19 Preparation 19 tert-butyl 4-{2-[({4-[4-{2-cyano-4-[(1,2,4-thiadiazol-5-ylamino)sulfonyl]phenoxy}-3'-(trifluoromethyl)biphenyl-3-yl]pyridin-2-yl}methyl)amino]ethyl}piperidine-1-carboxylate Preparation 19 tert-butyl 4-{2-[({4-[4-{2-cyano-4-[(1,2,4-thiadiazol-5-ylamino)sulfonyl]phenoxy}-3'-(trifluoromethyl)biphenyl-3-yl]pyridin-2-yl}methyl)amino]ethyl}piperidine-1-carboxylate To a suspension of 4-({3-[2-(aminomethyl)pyridin-4-yl]-3'-(trifluoromethyl)biphenyl-4- yl}oxy)-3-cyano-N-1 ,2,4-thiadiazol-5-ylbenzenesulfonamide bis-formate salt (Example 26, 50 mg, 0.071 mmol) in methanol (2 mL) was added triethylamine (20 μΙ_, 0.143 mmol) followed by tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (16 mg, 0.071 mmol). The reaction was stirred at room temperature for 18 hours and sodium borohydride (16 mg, 0.43 mmol) was added. After 30 minutes at room temperature, the mixture was quenched by the addition of water (5.0 mL). The aqueous phase was extracted with ethyl acetate (3 x 5 mL) and the combined organic layers were washed with brine (10 mL), dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. The residue was purified by reverse phase column chromatography eluting with 5-95% acetonitrile in water with 0.1 % formic acid to afford the title compound as a white solid (35 mg, 62%). 1 H NMR (400MHz, MeOD-d4): δ ppm 1.05 (m, 2H), 1.40 (s, 9H), 1.40-1.80 (m, 5H), 2.70 (m, 2H), 3.05 (m, 2H), 4.00 (d, 2H), 4.40 (s, 2H), 6.80 (d, 1 H), 7.40 (d, 1 H), 7.50 (d, 1 H), 7.60 (m, 2H), 7.80 (m, 3H), 7.95 (m, 3H), 8.05 (s, 1 H), 8.50 (d, 2H). 19F NMR (400MHz, MeOD-d4): δ ppm -64 (s, 3F). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
13% | Stage #1: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate; (±)-trans-2-phenylcyclopropylamine With acetic acid In chloroform at 20℃; for 18h; Stage #2: With sodium tris(acetoxy)borohydride In chloroform for 18h; | 23.a a) 1,1-dimethylethyl 4-(2-[trans-2-phenylcyclopropyl]amino}ethyl)-1-piperidinecarboxylate A mixture of [trans-2-phenylcyclopropyl]amine (668 mg, 5.02 mmol), 1,1-dimethylethyl 4-(2-oxoethyl)-1-piperidinecarboxylate (1.04 g, 4.58 mmol) and AcOH (1 μL, 0.017 mmol) in chloroform (5 mL) was stirred at room temperature for 18 hours. Sodium triacetoxyborohydride (1.03 g, 4.86 mmol) was added and stirring continued for 18 hours. Upon completion, saturated NaHCO3 was added to the reaction mixture and the mixture was extracted with THF-CHCl3 (2×50 mL). The organics were combined, dried over Na2SO4 and concentrated. The residue was adsorbed onto silica and purified via column chromatography on the ISCO Companion (gradient 0-100% 80:20:2 [CHCl3/MeOH/NH4OH]/CHCl3; 12 g column) to yield the desired product. This product was further purified via reverse phase column chromatography on Gilson ((C18 column: 0.1% Formic acid H2O/CH3CN, 95-5%) affording the title compound (222 mg, 13% yield) as a yellow oil: LC-MS (ES) m/z=345 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
13% | Stage #1: trans-2-phenylcyclopropylamine; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With acetic acid In chloroform at 20℃; for 18h; Stage #2: With sodium tris(acetoxy)borohydride In chloroform for 18h; | 23.a 1,1-dimethylethyl 4-(2-[trans-2-phenylcyclopropyl]amino}ethyl)-1-piperidinecarboxylate A mixture of [trans-2-phenylcyclopropyl]amine (668 mg. 5.02 mmol), 1,1-dimethylethyl 4-(2-oxoethyl)-1-piperidinecarboxylate (1.04 g. 4.58 mmol) and AcOH (1 μL, 0.017 mmol) in chloroform (5 mL) was stirred at room temperature for 18 hours. Sodium triacetoxyborohydride (1,03 g, 4.86 mmol) was added and stirring continued for18 hours. Upon completion. saturated NaHCO3 was added tothe reaction mixture and the mixture was extracted with THF-CHCl3, (2x50 mL). The organics were combined, dried over Na2SO4 and concentrated. The residue was adsorbed onto silica and purified via column chromatography on the ISCO Companion (gradient 0-100% 80:20:2 [CHCl3/MeOH/NH4OH]/CHC13; 12 g column) to yield the desired product. This product was further purified via reverse phase column chromatography on Gilson ((C18 Scolumn: 0.1% Formic acid H2O/CH3CN, 95-5%) affording the title compound (222 mg, 13% yield) as a yellow oil |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | Stage #1: 4-(diethyoxyphosphorylmethyl)benzoic acid methyl ester With sodium hydride In tetrahydrofuran at 0℃; for 1h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at 20℃; for 2h; | Step 3: (E)-tert-butyl 4-(3-(4-(methoxycarbonyl)phenyl)allyl)piperidine-1-carboxylate (LXXIII) To a stirred solution of methyl 4-((diethoxyphosphoryl)methyl)benzoate (0.9 g, 3.96 mmol) in dry THF (40 mL) was added 60 % sodium hydride at 0 °Cand stirred for1H. Solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (LXXII, 1.1 g, 3.96 mmol) in dry THF was added and stirred further 2 h at room temperature. The reaction mixture was quenched with saturated ammonium chloride and then extracted with ethyl acetate (100 mL). The organic portion was washed with water, brine, dried over sodium sulphate and concentrated under reduced pressure to get the crude product which was purified by column chromatographyusing ethylacetate-hexane gradient to afford the titled product as colourless liquid (LXXIII, 0.7 g, 50 %). LC-MS m/z calcd for C2iH29N04, 359.2; found 260.2 [M-Boc +H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93.3% | In dichloromethane at 0 - 20℃; for 3h; | ieri-Butyl (£)-4-(4-ethoxy-4-oxobut-2-en-1-yl)piperidine-1-carboxylate (11). fert-Butyl 4-(2-oxoethyl)piperidine-1 -carboxylate (10, 1 .14 g, 5.0 mmol, MW = 227.317, Aldrich or Fluochem, CAS 142374-19-4) was dissolved in CH2CI2 (20 mL), (carbethoxymethylene)triphenylphosphorane (3.14 g, 9.0 mmol) was added in small portions under vigorous stirring at 0 °C. The mixture stirred at 20 °C for 3 h, then concentrated, the residue was purified by FC (5/1 PE/EtOAc) to give 1 .39 g (93.3 %) of 11 (MW = 297.399) as colorless oil. 1H NMR (400 MHz, CDCI3): δ = 6.94 (dt, 1 H, J = 15.6 Hz, 7.7 Hz), 5.84 (dt, 1 H, J = 15.6 Hz, 1 .4 Hz), 4.20 (q, 2H, J = 7.0 Hz), 4.16-4.01 (m, 2H), 2.69 (t, 2H, J = 1 1 .4 Hz), 2.17 (t, 2H, J = 7.5 Hz), 1 .73-1 .64 (m, 2H), 1 .62-1 .54 (m, 1 H), 1 .47 (s, 9H), 1 .31 (t, 3H, J = 7.4 Hz), 1 .15 (qd, 2H, J= 1 1 .8 Hz, 3.0 Hz). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | Stage #1: bis-(2,2,2-trifluoroethyl)(methoxycarbonylmethyl)phosphonate With 18-crown-6 ether; potassium hexamethylsilazane In tetrahydrofuran; toluene at -78℃; for 0.5h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran; toluene at -78 - 20℃; for 0.5h; | 18-1 (Z) -tert-butyl 4- (4-methoxy-4-oxobut-2-enyl) piperidine-1-carboxylate To a solution of methyl 2- (bis (2, 2, 2-trifluoroethoxy) phosphoryl) acetate (1.9 g, 6 mmol) and 18-crown-6 (3.96 g, 15 mmol) in dry THF (70 mL) at -78 was dropwise added KHMDS (15 mL, 7.5 mmol, 0.5 M in toluene) . After stirring at -78 for 0.5h, tert-butyl 4- (2-oxoethyl) piperidine-1-carboxylate (1.14 g, 5 mmol) in dry THF (5 mL) was added to the mixture at -78 and the resulting mixture stirred at rt for 0.5h. The reaction was quenched with saturated aqueous NH4Cl (100 mL) and extracted with DCM (100 mL×3) . The combined organic layers was washed with brine (50 mL) , dried over anhydrous Na2SO4 and concentrated. The residue was purified by chromatography (silica gel: 300-400 mesh, PE/EtOAc 40/1 to 20/1) to afford (Z) -tert-butyl 4- (4-methoxy-4-oxobut-2-enyl) piperidine-1-carboxylate (1.1 g, 78) . LRMS m/z (M-100) 184.1 found, 184.1 required |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | With 2,6-dimethylpyridine; C21H22N2O2S In N,N-dimethyl-formamide at 15℃; Irradiation; enantioselective reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With pyridinium p-toluenesulfonate; magnesium sulfate In dichloromethane at 20℃; for 18h; | 1 Step 1 : Preparation of (S,E)-tert-butyl 4-(2-((tert-butylsulfinyl)imino)ethyl)piperidine-1 - carboxylate To a solution of (S)-2-methylpropane-2-sulfinamide (1.76 g, 14.5 mmol) in DCM (36 mL) was added PPTS (0.166 g, 0.660 mmol) and magnesium sulfate (3.97 g, 33.0 mmol) followed by N-Boc-piperidineacetaldehyde (3.00 g, 13.2 mmol) and the mixture was stirred at ambient temperature for 18 hours. The mixture was filtered and the filtrate concentrated. The material was subjected to flash chromatography (silica gel, dry loading, 0-40% EtOAc/hexanes, gradient elution) to provide the title compound (4.04 g, 93 % yield) as an off-white solid. LCMS (ESI) m/z calcd for Ci6H3oN2S: 330.2. Found: 331.4 (M+1)+. NMR (400 MHz, CDCI3) δ 8.05 (t, J = 4.9 Hz, 1H), 4.07 (br s, 2H), 2.70 (t, J = 12.1Hz, 2H), 2.41 - 2.53 (m, 2H), 1.91 (ddd, J = 1 1.0, 7.3, 3.9 Hz, 1H), 1.64 - 1.77 (m, 3H), 1.44 (s, 9H), 1.1 1 - 1.27 (m, 10H). |
83% | With titanium(IV) isopropylate In dichloromethane at 20℃; for 6h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 2,6-dimethylpyridine; (2R,5S)-5-methyl-2-tert-butyl-3-methylimidazolidin-4-one In N,N-dimethyl-formamide at 20℃; Sealed tube; Irradiation; Inert atmosphere; | 2.4. Photocatalytic α-alkylation of aldehydes General procedure: To an oven-dried 10 mL glass vial were added MSN-AP-Pt1(1 mol% of Pt), diethyl 2-bromomalonate 1a (0.1 mmol), the corresponding aldehyde 3 (0.2 mmol) and MacMillan’s imidazolidinone catalyst (20 mol%). Then, 200 lL of anhydrous DMF and 2,6-lutidine (0.2 mmol) were added to the vial. The vial was sealed with a PTFE/rubber septum and the reaction mixture was degassed by three cycles of freeze-pump-thaw. Afterwards, the reaction mixture was stirred and irradiated using blue LED irradiation(see S.I. for more details) at rt. The reaction progress was monitored by 1H NMR. | |
With morpholine; 2,6-dimethylpyridine; (R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum(III) chloride In N,N-dimethyl-formamide at 20℃; for 18h; Inert atmosphere; Schlenk technique; Irradiation; enantioselective reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53.5% | Stage #1: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With phenyltrimethylammonium tribromide In tetrahydrofuran at 0℃; for 1h; Inert atmosphere; Stage #2: thiourea In ethanol at 80℃; for 3h; | 28 Compound F3: To a solution of compound F1 (15 g, 66 mmol) in THF (50 mL) was added phenyltrimethylammonium tribromide (37.2 g, 99 mmol) at 0. The mixture was stirred at 0 under N 2 for 1 hours. The mixture was quenched with water (50 mL) and extracted with EtOAc (200 mL × 2) . The organic phase was washed with brine (100 mL) , dried over anhydrous Na 2SO 4, concentrated to give the residue (7.5 g) . The residue was dissolved in ethanol (200 mL) was added compound F2 (7.5 g, 99 mmol) . The mixture was stirred at 80 for 3 h. The mixture was cooled to room temperature and concentrated under reduced pressure to afford the crude product, which was purified by silica gel chromatography (elution gradient: EA/PE, 1/1, v/v) . Pure fractions were evaporated to dryness to afford compound F3 (10 g) as a pale-yellow solid, yield: 53.5%. 1H NMR (400 MHz, CDCl 3) : δ ppm 1.48 (s, 9H) , 1.53-1.60 (m, 2H) , 1.90-1.96 (m, 2H) , 2.77-2.85 (m, 3H) , 4.17 (s, 2H) , 6.78 (s, 1H) . LCMS: Rt = 1.20 min, MS Calcd.: 283.1, MS Found: 283.9 [M+H] +. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | Stage #1: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate; 1-(1-phenylvinyl)cyclobutan-1-ol With (2R,5R)-2-tert-butyl-3-methyl-5-(naphthalen-1-ylmethyl)imidazolidin-4-one trifluoroacetic acid salt In 1,2-dimethoxyethane at -20℃; for 0.0833333h; Inert atmosphere; Stage #2: With disodium hydrogenphosphate; tris(1,10-phenanthroline)iron(III) tris(hexafluorophosphate) In 1,2-dimethoxyethane at -20℃; for 24h; Inert atmosphere; stereoselective reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | Stage #1: 2-[2-(cyclopropylmethylamino)-4-pyridyl]-N-[3-(difluoromethyl)-1-(4-piperidyl)pyrazol-4-yl]oxazole-4-carboxamide hydrochloride; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With triethylamine In tetrahydrofuran; N,N-dimethyl-formamide at 10℃; for 1h; Inert atmosphere; Stage #2: With sodium tris(acetoxy)borohydride In tetrahydrofuran; N,N-dimethyl-formamide at 10℃; for 12h; Inert atmosphere; | 1 Step 1 - Tert-butyl 4-[2-[4-[4-[[2-[2-(cyclopropylmethylamino)-4-pyridyl]oxazole- 4-carbonyl]amino]- 3-(difluoromethyl)pyrazol-1-yl]-1-piperidyl]ethyl]piperidine-1-carboxylate To a solution of 2-[2-(cyclopropylmethylamino)-4-pyridyl]-N-[3-(difluoromethyl)- 1-(4-piperidyl) pyrazol-4-yl] oxazole-4-carboxamide (217 mg, 439 umol, HCl salt, Intermediate AAY) in a mixed solvents of DMF (2 mL) and THF (3 mL) was added TEA until the pH = 7 - 8, and acidified with AcOH until the pH = 5 - 6. Then tert-butyl 4-(2-oxoethyl) piperidine-1- carboxylate (100 mg, 439 umol, CAS 142374-19-4) was added. The reaction mixture was stirred at 10 °C for 1 hour. Then, NaBH(OAc)3(186 mg, 879 umol) was added. The reaction mixture was stirred at 10 °C for 12 hours. On completion, the reaction mixture was quenched by water (0.2 mL), filtered and the filtrate was concentrated in vacuo. The residue was purified by reverse phase (0.1% FA) to give title compound (230 mg, 78% yield) as white solid.1H NMR (400 MHz, CDCl3) d 9.05 (s, 1H), 8.36 - 8.34 (m, 2H), 8.20 (d, J = 5.2 Hz, 1H), 7.20 (dd, J = 1.2, 5.2 Hz, 1H), 7.05 (s, 1H), 6.99 - 6.66 (m, 1H), 5.57 - 5.23 (m, 1H), 4.26 - 4.15 (m, 2H), 4.14 - 4.01 (m, 2H), 3.23 (d, J = 6.8 Hz, 2H), 3.21 - 3.11 (m, 2H), 2.69 (t, J = 11.6 Hz, 2H), 2.63 - 2.54 (m, 2H), 2.47 - 2.33 (m, 2H), 2.31 - 2.14 (m, 4H), 1.70 - 1.61 (m, 2H), 1.58 - 1.51 (m, 2H), 1.46 (s, 9H), 1.24 - 1.05 (m, 3H), 0.65 - 0.56 (m, 2H), 0.35 - 0.28 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35% | Stage #1: 1-(azetidin-3-yl)-3-(difluoromethyl)-4-nitropyrazole trifluoroacetic acid salt With triethylamine In tetrahydrofuran; N,N-dimethyl-formamide at 25℃; for 0.2h; Inert atmosphere; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With acetic acid In tetrahydrofuran; N,N-dimethyl-formamide at 25℃; for 0.5h; Inert atmosphere; Stage #3: With sodium tris(acetoxy)borohydride In tetrahydrofuran; N,N-dimethyl-formamide at 25℃; for 12h; Inert atmosphere; | 1 Step 1 - Tert-butyl 4-[2-[3-[3-(difluoromethyl)-4-nitro-pyrazol-1-yl]azetidin-1- yl]ethyl]piperidine-1- carboxylate To a mixture of 1-(azetidin-3-yl)-3-(difluoromethyl)-4-nitro-pyrazole (1.40 g, 4.21 mmol, TFA salt, Intermediate ABH) in DMF (3 mL) and THF (5 mL) was added TEA (426 mg, 4.21 mmol, 586 uL) and stirred at 25 °C for 12 min. Then tert-butyl 4-(2-oxoethyl)piperidine-1- carboxylate (957 mg, 4.21 mmol) and HOAc (253 mg, 4.21 mmol, 241 uL) was added to the mixture and stirred at 25 °C for 0.5 hour. Finally NaBH(OAc)3(1.79 g, 8.43 mmol) was added to the mixture at 25 °C. The reaction mixture was stirred at 25 °C for 12 hours. On completion, the reaction mixture was quenched with water (0.1 mL) and concentrated in vacuo. The residue was purified by reverse phase (0.1 % FA condition) to give the title compound (640 mg, 35% yield) as white solid;1H NMR (400 MHz, DMSO-d6) d 9.24 (s, 1H), 7.39 (t, J = 52.4 Hz, 2H), 5.53 - 5.38 (m, 1H), 4.60 - 4.43 (m, 2H), 4.47 - 4.25 (m, 2H), 3.91 (d, J = 12.0 Hz, 2H), 3.31 - 3.25 (m, 3H), 2.78 - 2.60 (m, 2H), 1.62 (d, J = 12.8 Hz, 2H), 1.46 - 1.41 (m, 2H), 1.38 (s, 9H), 1.06 - 0.93 (m, 2H); LC-MS (ESI+) m/z 430.3 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | Stage #1: N-[3-(difluoromethyl)-1-(4-piperidyl)pyrazol-4-yl]-5-morpholinopyrazolo[1,5-a]pyrimidine-3-carboxamide hydrochloride With triethylamine In tetrahydrofuran; N,N-dimethyl-formamide at 20℃; for 0.25h; Inert atmosphere; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With acetic acid In tetrahydrofuran; N,N-dimethyl-formamide at 20℃; for 0.5h; Inert atmosphere; Stage #3: With sodium tris(acetoxy)borohydride In tetrahydrofuran; N,N-dimethyl-formamide at 20℃; for 12h; Inert atmosphere; | 1 Step 1 - Tert-butyl 4-[2-[4-[3-(difluoromethyl)-4-[(5-morpholinopyrazolo[1,5- a]pyrimidine-3- carbonyl)amino]pyrazol-1-yl]-1-piperidyl]ethyl]piperidine-1-carboxylate To a solution of N-[3-(difluoromethyl)-1-(4-piperidyl)pyrazol-4-yl]-5-morpholino- pyrazolo[1,5-a] pyrimidine-3-carboxamide (200 mg, 414 umol, HCl, Intermediate AEJ) in DMF (3 mL) and THF (6 mL) was added TEA (41.9 mg, 414 umol, 57.6 uL), the mixture was stirred at 20 °C for 15 mins, then tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (94.1 mg, 414 umol, CAS 142374-19-4) and HOAc (49.7 mg, 828 umol, 47.3 uL) was added to the mixture, the reaction mixture was stirred at 20 °C for 30 mins. Then NaBH(OAc)3 (131 mg, 621 umol ) was added to the mixture, the reaction mixture was stirred at 20 °C for 12 hours. On completion, the reaction mixture was quenched with water (0.5 mL), filtered and the filtrate was concentrated in vacuo. The residue was purified by reverse phase (0.1% FA) to give title compound (210 mg, 77% yield) as white solid.1H NMR (400 MHz, DMSO-d6) d 9.39 (s, 1H), 8.82 (d, J = 8.0 Hz, 1H), 8.39 (s, 1H), 8.29 (s, 1H), 7.26 - 6.95 (m, 1H), 6.90 (d, J = 8.0 Hz, 1H), 4.30 - 4.16 (m, 1H), 3.90 (d, J = 12.4Hz, 2H), 3.84 - 3.76 (m, 4H), 3.75 - 3.67 (m, 4H), 3.00 - 2.90 (m, 2H), 2.75 - 2.60 (m, 2H), 2.35 (t, J = 7.2 Hz, 2H), 2.11 - 1.85 (m, 6H), 1.69 - 1.57 (m, 2H), 1.51 - 1.42 (m, 1H), 1.42 - 1.33 (m, 11H), 1.06 - 0.91 (m, 2H); LC-MS (ESI+) m/z 658.5 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92.75% | Stage #1: 2-(2,6-dioxopiperidin-3-yl)-5-(piperazin-1-yl)isoindoline-1,3-dione; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere; Stage #2: With sodium tris(acetoxy)borohydride In N,N-dimethyl-formamide at 20℃; for 2h; Inert atmosphere; | 6.3 Step 3: Preparation of tert-butyl 4-(2-[4-[2-(2, 6-dioxopiperidin -3-yI)-l, 3-dioxoisoindol-5-yI]piperazin-1-yI]ethyl)piperidine- 1-carboxylate To a stirred solution of 2-(2,6-dioxopiperidin-3-yl)-5-(piperazin-1-yl)isoindole-1,3-dione (2.00 g, 5.842 mmol, 1.00 equivalent) in DMF (25.00 mL) was added tert-butyl 4-(2-oxoethyl)piperidine-1- carboxylate (1 .33 g, 5.842 mmol, 1 .00 equivalent) under nitrogen atmosphere. The resulting mixture wasstirred for 16h at room temperature under nitrogen atmosphere. To the above mixture was added NaBH(OAc)3 (2.48 g, 11 .684 mmol, 2.00 equivalent). The resulting mixture was stirred for additional 2 hours at room temperature. The resulting mixture was diluted with water (70 mL). The aqueous layer was extracted with EtOAc (4 x 30 mL). The organic layers were concentrated under vacuum. The residue was purified by silica gel column chromatography, eluted with DCM:MeOH (50:1 to 10:1) to afford tert20 butyl 4-(2-[4-[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxoisoindol-5-yl]piperazin-1 -yl]ethyl)piperidine-1 -carboxylate (3 g, 92.75%) as a yellow oil. LCMS (ESI) mlz: [M+H]+ = 554. |
61.06% | With sodium tris(acetoxy)borohydride at 25℃; for 1h; | 48.3 Step 3: Preparation of tert-butyl 4-(2-(4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperazin-1- yl)ethyl)piperidine-1-carboxylate (i42-5) To a solution of 2-(2,6-dioxopiperidin-3-yl)-5-(piperazin-1-yl)isoindole-1,3-dione (200.00 mg, 0.584 mmol, 1.00 equiv) and tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (132.79 mg, 0.584 mmol, 1 equiv) in DMF (3.00 mL) was added NaBH(OAc)3 (247.63 mg, 1.168 mmol, 2 equiv). The resulting solution was stirred at 25 °C for 1 hour. The residue was purified by reverse flash chromatography (conditions: column, C18 silica gel; mobile phase, ACN in water, 10% to 50% gradient in 10 minutes; detector, UV 254 nm) to give tert-butyl 4-(2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin- 1-yl]ethyl)piperidine-1-carboxylate (197.5 mg, 61.06%) as a yellow solid. LCMS (ESI) m/z: [M+H]+ = 554. |
3 g | Stage #1: 2-(2,6-dioxopiperidin-3-yl)-5-(piperazin-1-yl)isoindoline-1,3-dione; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In N,N-dimethyl-formamide at 15℃; for 16h; Inert atmosphere; Stage #2: With sodium tris(acetoxy)borohydride In N,N-dimethyl-formamide at 15℃; for 2h; Inert atmosphere; | 54.3 Step 3: tert-butyl 4-(2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl)piperidine- 1-carboxylate To a stirred solution of 2-(2,6-dioxopiperidin-3-yl)-5-(piperazin-1-yl)isoindole-1,3-dione (2.00 g, 5.842 mmol, 1.00 equivalent) in DMF (25.00 mL) were added tert-butyl 4-(2-oxoethyl)piperidine-1- carboxylate (1.33 g, 5.842 mmol, 1.00 equivalent) under nitrogen atmosphere. The resulting mixture was stirred for 16 hours at 15 oC under nitrogen atmosphere. To the above mixture was added NaBH(OAc)3 (2.48 g, 11.684 mmol, 2.00 equivalent) at 15 oC. The resulting mixture was stirred for additional 2 hours at 15 oC. The resulting mixture was diluted with water (70 mL). The aqueous layer was extracted with EtOAc (4x30 mL). The organic layers were concentrated under vacuum. The residue was purified by silica gel column chromatography, eluted with DCM:MeOH (50:1 to 10:1) to afford tert-butyl 4-(2-[4-[2- (2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl)piperidine-1-carboxylate (3 g, 92.75%) as a yellow oil. LCMS (ESI) m/z: [M+H]+ = 555. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With sodium cyanoborohydride; acetic acid at 20℃; for 12h; | 4.1.23. Synthesis of tert-butyl 4-((4-(4-(((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl) carbamoyl) phenyl)piperazin-1-yl)methyl)piperidine-1-carboxylate (27a) General procedure: To a mixture of 15 (700 mg, 1.49 mmol), tert-butyl 4-formylpiperidine-1-carboxylate (1.3 g, 5.99 mmol), and AcOH(1.0 mL) in MeOH (15 mL) was added NaBH3CN (561 mg,8.94 mmol). The mixture was stirred at room temperature for 12 h.The reaction mixture was concentrated under reduced pressure.The residue was quenched with saturated NaHCO3 solution andextracted with dichloromethane. The organic layer was washedwith brine, dried over Na2SO4, and concentrated under reducedpressure. The residue was purified by column chromatography toafford 27a (700 mg, 70%) as a white solid |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | Stage #1: 5-[6-(benzyloxy)-8-fluoro-1,2,3,4-tetrahydroisoquinolin-7-yl]-1λ6,2,5-thiadiazolidine-1,1,3-trione trifluoroacetate With triethylamine In dichloromethane at 20℃; for 0.0833333h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In dichloromethane for 0.166667h; Stage #3: With sodium tris(acetoxy)borohydride In dichloromethane at 20℃; for 16h; | 131.131A Example 131A: tert-butyl 4-{2-[6-(benzyloxy)-8-fluoro-7-(1,1,4-trioxo-1l6,2,5-thiadiazolidin-2- yl)-3,4-dihydroisoquinolin-2(1H)-yl]ethyl}piperidine-1-carboxylate Triethylamine (0.083 mL, 0.594 mmol) was added to 5-[6-(benzyloxy)-8-fluoro- 1,2,3,4-tetrahydroisoquinolin-7-yl]-1l6,2,5-thiadiazolidine-1,1,3-trione 2,2,2-trifluoroacetate (150 mg, 0.297 mmol, Example 54A) in dichloromethane (5 mL) and the mixture was stirred at ambient temperature for 5 minutes. tert-Butyl 4-(2-oxoethyl)piperidine-1-carboxylate (130 mg, 0.572 mmol) was then added and the mixture was stirred for a further 10 minutes. Then, sodium triacetoxyhydroborate (157 mg, 0.742 mmol) was added, and the reaction mixture was stirred at ambient temperature for 16 hours. The reaction mixture was diluted with dichloromethane (5 mL) and stirred with saturated sodium bicarbonate (20 mL) for 20 minutes. The mixture was extracted with dichloromethane. The organic fractions were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by reversed-phase column chromatography (120 g Agela Technologies Claricep Flash C18100 Å 40-60 mm column, flow rate 50 mL/minute, 10 to 100% methanol in water [buffered with 0.025 M aqueous ammonium bicarbonate, adjusted to pH 7 with CO2(s)]) to give the title compound (173.2 mg, 0.287 mmol, 97% yield). MS (APCI+) m/z 603 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With copper(II) sulfate In dichloromethane for 24h; | 3.3.39. Tert-butyl 4-(2-((tert-butylsulfinyl)imino)ethyl)piperidine-1-carboxylate (18b) Tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (5.66 g,25 mmol, 1 equiv.) was dissolved in CH2Cl2 (25 mL) and (S)-()-2-methyl-2-propanesulfinamide (3.32 g, 27 mmol, 1.1 equiv.) wasadded followed by anhydrous CuSO4 (9.94 g, 62 mmol, 2.5 equiv.)addition. The reaction mixture was vigorously stirred for 1 day (atthis point, TLC indicated consumption of starting material). Hexane(~100 mL) was added to the reaction mixture, and it was filteredthrough 1e2 cm plug of silica gel. The precipitate was washed withthe hexane-EtOAc mixture (1:1, 2x100 mL), and the filtrate wasevaporated. The residue was used without further purification.M(fS) 7.56 g. Yield 92%.Reaction with (R)-(+)-2-methyl-2-propanesulfinamide wasperformed in the same way.M(fR) 7.73 g. Yield 92%.1H NMR: (CDCl3, 400 MHz) δ 1.09-1.30 (m, 2H), 1.17 (s, 9 H),1.43 (s, 9 H), 1.64e1.73 (m, 2 H), 1.80e1.97 (m, 1 H), 2.45 (t,J 5.4 Hz, 2 H), 2.69 (t, J 10.3 Hz, 2 H), 3.87e4.31 (m, 2 H), 8.03 (t,J 5.0 Hz, 1 H).13C NMR: (CDCl3, 100 MHz) δ 22.5, 28.5, 32.1, 33.7, 42.8, 43.9(br.), 56.7, 79.5, 154.8, 168.3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With copper(II) sulfate In dichloromethane for 24h; | 3.3.39. Tert-butyl 4-(2-((tert-butylsulfinyl)imino)ethyl)piperidine-1-carboxylate (18b) Tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (5.66 g,25 mmol, 1 equiv.) was dissolved in CH2Cl2 (25 mL) and (S)-()-2-methyl-2-propanesulfinamide (3.32 g, 27 mmol, 1.1 equiv.) wasadded followed by anhydrous CuSO4 (9.94 g, 62 mmol, 2.5 equiv.)addition. The reaction mixture was vigorously stirred for 1 day (atthis point, TLC indicated consumption of starting material). Hexane(~100 mL) was added to the reaction mixture, and it was filteredthrough 1e2 cm plug of silica gel. The precipitate was washed withthe hexane-EtOAc mixture (1:1, 2x100 mL), and the filtrate wasevaporated. The residue was used without further purification.M(fS) 7.56 g. Yield 92%.Reaction with (R)-(+)-2-methyl-2-propanesulfinamide wasperformed in the same way.M(fR) 7.73 g. Yield 92%.1H NMR: (CDCl3, 400 MHz) δ 1.09-1.30 (m, 2H), 1.17 (s, 9 H),1.43 (s, 9 H), 1.64e1.73 (m, 2 H), 1.80e1.97 (m, 1 H), 2.45 (t,J 5.4 Hz, 2 H), 2.69 (t, J 10.3 Hz, 2 H), 3.87e4.31 (m, 2 H), 8.03 (t,J 5.0 Hz, 1 H).13C NMR: (CDCl3, 100 MHz) δ 22.5, 28.5, 32.1, 33.7, 42.8, 43.9(br.), 56.7, 79.5, 154.8, 168.3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With H<SUB>2</SUB>Ru(CO)(PPh<SUB>3</SUB>)<SUB>3</SUB>; (R)-2,2'-bis(diphenylphosphanyl)-1,1'-binaphthyl; isopropyl alcohol; lithium iodide In di-isopropyl ether at 75℃; for 48h; Inert atmosphere; Sealed tube; stereoselective reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | In dichloromethane at 30℃; for 10h; | 24.1 Step 1 Preparation of tert-butyl 4-[(E)-4-methoxy-4-oxo-but-2-enyl]piperidme-l- carboxylate To a solution of tert-butyl 4-(2-oxoethyl)piperidine-l-carboxylate (5.00 g, 22.00 mmol, 1.00 eq) in dichloromethane (100 niL) was added methyl 2-(triphenyl-phosphanylidene)acetate (8.09 g, 24.20 mmol, 1.10 eq). Then the mixture was stirred for 10 h at 30 °C. Thin layer chromatography (petroleum ether: ethyl acetate = 5:1) showed that the reaction was completed. The mixture was concentrated under reduced pressure to give the residue. The residue was dissolved by (Petroleum ether: ethyl acetate =10: 1, 100 niL). Then the mixture was filtered. The filtrate was concentrated under reduced pressure to give tert-butyl 4-[(E)-4-methoxy-4-oxo-but-2- enyl]piperidine-l-carboxylate (6.20 g, 21.88 mmol, 99 % yield) as a colorless oil, which was used in next step directly. ’ NMR: (400 MHz, DMSO~de)5: 6.79 - 693 (m, 1 H), 5 76 (dt, 1=15.6, 1.2 Hz, 1 H), 3 95 - 4.07 (m, 2 H), 3.66 (s, 3 H), 2.61 (td, 1=12.8, 2.8 Hz, 2 H), 2 04 - 2.17 (m, 2 H), 1.56-1.64 (m, 2 H), 1.44 - 1.56 (m, 1 H), 1.38 (s, 9 H), 0.99 - 1.13 (m, 2 H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | Stage #1: C24H24ClN7; tert-butyl 4-(formylmethyl)piperidine-1-carboxylate With acetic acid In 1,2-dichloro-ethane at 20℃; for 0.5h; Stage #2: With sodium tris(acetoxy)borohydride In 1,2-dichloro-ethane for 2h; | 3 Example 3 Preparation of TJA-116 compound Intermediate 76 (200mg, 1.0eq.) and compound 85 (122mg, 1.2eq.) were dissolved in 10mL DCE, 2 drops of acetic acid were added, stirred at room temperature for 0.5h, and NaBH(AcO)3 (236mg, 2.5eq.) was added After stirring for 2 hours, TLC detected the complete reaction of the raw materials, the reaction solution was concentrated, and purified by column chromatography (V dichloromethane/V methanol=80/1-20/1) to obtain 265 mg of white solid with a yield of 90%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With tris-(trimethylsilyl)silane; t-butyldimethylsiyl triflate In dichloromethane at 20℃; for 8h; Irradiation; Molecular sieve; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With sodium tris(acetoxy)borohydride In 1,2-dichloro-ethane at 20℃; for 1h; | 15 EXAMPLE 15 Synthesis of tert-butyl 4-(2-((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4- yl)amino)ethyl)piperidine-l-carboxylate (Compound Q) [1005] To a 10 mL round bottom flask equipped with a magnetic stirring bar was added tert-butyl 4-(2-oxoethyl)piperidine-l-carboxylate (0.1 g, 0.38 mmol, 1.0 equiv), 3-(4- amino-l-oxoisoindolin-2-yl)piperidine-2,6-dione (0.1 g, 0.46 mmol, 1.2 equiv) and DCE (3 mL). NaBH(OAc)3 (0.12 g, 0.57 mmol, 1.5 equiv) was added. The solution was stirred at rt for 1 h until LC-MS detected the reaction to be complete. The DCE was removed by evaporation, and water and MeCN were added. The crude product was directly purified by HPLC (MeCN/FbO 40%-100%, 60 min, 60 mL/min, the product came out when MeCN was 48.3%) to afford tert-butyl 4-(2-((2-(2,6-dioxopiperidin-3-yl)- l-oxoisoindolin-4-yl)amino)ethyl)piperidine-l-carboxylate (80% yield). The Boc was removed with TFA/DCM = 1/1 before the next step. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | Stage #1: 3-iodopyridine With isopropylmagnesium chloride In tetrahydrofuran at 0℃; for 0.5h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at 0 - 25℃; for 1.5h; | 9.1 Step 1 : Preparation of tert-butyl 4-[2-hydroxy-2-(3-pyridyl)ethyl]piperidine-1-carboxylate. To a solution of 3-iodopyridine (1.44 g, 7.04 mmol) in tetrahydrofuran (15 ml_) was added isopropylmagnesium chloride (2 M, 3.52 ml_) in tetrahydrofuran at 0 °C. The mixture was stirred at 0 °C for 30 minutes. Then, tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (0.8 g, 3.52 mmol) was added at 0 °C. Then the mixture was warmed and stirred at 25 °C for 1.5 hours. Saturated ammonium chloride solution (20 ml_) was added to the reaction, and the reaction mixture was extracted with ethyl acetate (30 ml_ x 2). The combined organic layers were washed with brine (20 ml_), dried over sodium sulfate, filtered, and concentrated to dryness. The crude product was purified by ISCO column chromatography (10 g silica, 50-100 % ethyl acetate in petroleum ether, gradient over 40 minutes) to obtain tert-butyl 4-[2-hydroxy-2-(3-pyridyl)ethyl]piperidine-1-carboxylate (0.94 g, 3.07 mmol, 87%) as a pale yellow solid. 1H NMR (400 MHz, Chloroform-d) d 8.45 (d, J = 1.6 Hz, 1H), 8.41 (dd, J = 1.5, 4.6 Hz, 1H), 7.64 (br. d, J = 7.8 Hz, 1H), 7.26 - 7.19 (m, 1H), 4.76 (dd, J = 4.6, 9.0 Hz, 1H), 4.10 - 3.92 (m, 2H), 2.70 - 2.53 (m, 2H), 1.78 - 1.66 (m, 2H), 1.64 - 1.53 (m, 2H), 1.52 - 1.42 (m, 1H), 1.38 (s, 9H), 1.15 - 1.02 (m, 2H). |
87% | Stage #1: 3-iodopyridine With isopropylmagnesium chloride In tetrahydrofuran at 0℃; for 0.5h; Stage #2: tert-butyl 4-(formylmethyl)piperidine-1-carboxylate In tetrahydrofuran at 0 - 25℃; for 1.5h; | 9.1 Step 1 : Preparation of tert-butyl 4-[2-hydroxy-2-(3-pyridyl)ethyl]piperidine-1-carboxylate. To a solution of 3-iodopyridine (1.44 g, 7.04 mmol) in tetrahydrofuran (15 ml_) was added isopropylmagnesium chloride (2 M, 3.52 ml_) in tetrahydrofuran at 0 °C. The mixture was stirred at 0 °C for 30 minutes. Then, tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (0.8 g, 3.52 mmol) was added at 0 °C. Then the mixture was warmed and stirred at 25 °C for 1.5 hours. Saturated ammonium chloride solution (20 ml_) was added to the reaction, and the reaction mixture was extracted with ethyl acetate (30 ml_ x 2). The combined organic layers were washed with brine (20 ml_), dried over sodium sulfate, filtered, and concentrated to dryness. The crude product was purified by ISCO column chromatography (10 g silica, 50-100 % ethyl acetate in petroleum ether, gradient over 40 minutes) to obtain tert-butyl 4-[2-hydroxy-2-(3-pyridyl)ethyl]piperidine-1-carboxylate (0.94 g, 3.07 mmol, 87%) as a pale yellow solid. 1H NMR (400 MHz, Chloroform-d) d 8.45 (d, J = 1.6 Hz, 1H), 8.41 (dd, J = 1.5, 4.6 Hz, 1H), 7.64 (br. d, J = 7.8 Hz, 1H), 7.26 - 7.19 (m, 1H), 4.76 (dd, J = 4.6, 9.0 Hz, 1H), 4.10 - 3.92 (m, 2H), 2.70 - 2.53 (m, 2H), 1.78 - 1.66 (m, 2H), 1.64 - 1.53 (m, 2H), 1.52 - 1.42 (m, 1H), 1.38 (s, 9H), 1.15 - 1.02 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63.4% | With sodium tris(acetoxy)borohydride In dichloromethane at 20℃; for 16h; | 1 Step 1: tert-butyl (S)-4-(2-(4-(2-(2-hydroxyphenyl)-5,6,6a,7,9,10-hexahydro-8H-pyrazino[1',2':4,5]pyrazino[2,3-c]pyridazin-8-yl)piperidin-1-yl)ethyl)piperidine-1-carboxylate [0457] To a solution of Int-11 (30.0 mg, 0.08 mmol) and tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (27.91 mg, 0.12 mmol) in DCM (30 mL) was added NaBH(OAc)3 (34 mg, 0.16 mmol) at rt. The mixture was stirred at rt for 16 h. The volatiles were removed in vacuum and the residue was purified by prep-TLC (MeOH : DCM = 1 : 10) to give tert-butyl (S)-4-(2-(4-(2-(2-hydroxyphenyl)-5,6,6a,7,9,10-hexahydro-8H-pyrazino[1',2':4,5]pyrazino[2,3-c]pyridazin-8-yl)piperidin-1-yl)ethyl)piperidine-1-carboxylate (30.0 mg, 0.051 mmol, 63.4% yield) as a yellow solid. LCMS m/z calcd for C32H48N7O3 [M+H]+: 578.4; Found: 578.1. |
63.4% | With sodium tris(acetoxy)borohydride In dichloromethane at 20℃; for 16h; | 1 Step 1: tert-butyl (S)-4-(2-(4-(2-(2-hydroxyphenyl)-5,6,6a,7,9,10-hexahydro-8H-pyrazino[1',2':4,5]pyrazino[2,3-c]pyridazin-8-yl)piperidin-1-yl)ethyl)piperidine-1-carboxylate [0457] To a solution of Int-11 (30.0 mg, 0.08 mmol) and tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (27.91 mg, 0.12 mmol) in DCM (30 mL) was added NaBH(OAc)3 (34 mg, 0.16 mmol) at rt. The mixture was stirred at rt for 16 h. The volatiles were removed in vacuum and the residue was purified by prep-TLC (MeOH : DCM = 1 : 10) to give tert-butyl (S)-4-(2-(4-(2-(2-hydroxyphenyl)-5,6,6a,7,9,10-hexahydro-8H-pyrazino[1',2':4,5]pyrazino[2,3-c]pyridazin-8-yl)piperidin-1-yl)ethyl)piperidine-1-carboxylate (30.0 mg, 0.051 mmol, 63.4% yield) as a yellow solid. LCMS m/z calcd for C32H48N7O3 [M+H]+: 578.4; Found: 578.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With trifluoroacetic acid In dichloromethane at 20℃; for 2h; | Step 1: Preparation of 2-(piperidin-4-yl)acetaldehyde To a solution of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (580 mg, 2.72 mol) in dichloromethane (10 mL) was added trifluoroacetic acid (1.5 mL). The reaction solution was stirred at room temperature for 2 h. The reaction was concentrated under reduced pressure to give 320 mg of oil, which was used directly in the next reaction. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
700 mg | With sodium tris(acetoxy)borohydride In tetrahydrofuran at 20℃; | step 1: Preparation of 4-(2-(4-(6-Methoxy-5-(6-(trifluoromethyl)picolinamido)-2H-indazol-2-yl)piperidin-1-yl)ethyl)tert-butyl piperidine-1-carboxylate To N-(6-methoxy-2-(piperidin-4-yl)-2H-indazol-5-yl)-6-(trifluoromethyl)picolinamide (1.0 g, 2.386 mmol) and To a mixture of tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (0.813 g, 3.581 mmol) in tetrahydrofuran (20 mL) was added sodium triacetoxyborohydride (1.518 g, 7.160 mmol). The reaction solution was stirred at room temperature overnight. The reaction solution was diluted with ethyl acetate (50 mL), washed with water (2×50 mL) and saturated brine (50 mL), the organic phase was collected, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate was purified by column chromatography to obtain 700 mg of the target product as a yellow solid. |
700 mg | With sodium tris(acetoxy)borohydride In tetrahydrofuran at 20℃; | 2.7 Step 7: Preparation of 4-(2-(4-(6-Methoxy-5-(6-(trifluoromethyl)picolinamido)-2H-indazol-2-yl)piperidin-1-yl ) ethyl) piperidine-1-carboxylate tert-butyl ester To N-(6-methoxy-2-(piperidin-4-yl)-2H-indazol-5-yl)-6-(trifluoromethyl)picolinamide (1.0 g, 2.386 mmol) and tert-butyl 4-(2-oxoethyl)piperidine-1-carboxylate (0.813 g, 3.581 mmol) in tetrahydrofuran (20 mL) was added STAB (1.518 g, 7.160 mmol).The reaction solution was stirred at room temperature overnight.The reaction solution was diluted with ethyl acetate (50 mL), washed with water (2×50 mL) and saturated brine (50 mL), the organic phase was collected, dried over anhydrous sodium sulfate, and concentrated under reduced pressure.The concentrate was purified by silica gel column to obtain 700 mg of the target product as a yellow solid. |
[ 137076-22-3 ]
tert-Butyl 4-formylpiperidine-1-carboxylate
Similarity: 0.98
[ 189442-92-0 ]
1-Boc-4-Formyl-4-methylpiperidine
Similarity: 0.98
[ 118156-93-7 ]
tert-Butyl 3-formylpiperidine-1-carboxylate
Similarity: 0.94
[ 157634-02-1 ]
tert-Butyl 2-formylpiperidine-1-carboxylate
Similarity: 0.89
[ 59379-02-1 ]
tert-Butyl 3-formylpyrrolidine-1-carboxylate
Similarity: 0.88
[ 137076-22-3 ]
tert-Butyl 4-formylpiperidine-1-carboxylate
Similarity: 0.98
[ 189442-92-0 ]
1-Boc-4-Formyl-4-methylpiperidine
Similarity: 0.98
[ 873924-08-4 ]
tert-Butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate
Similarity: 0.96
[ 154775-43-6 ]
3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)propanoic acid
Similarity: 0.94
[ 872850-31-2 ]
2-(1-(tert-Butoxycarbonyl)-4-methylpiperidin-4-yl)acetic acid
Similarity: 0.94
[ 137076-22-3 ]
tert-Butyl 4-formylpiperidine-1-carboxylate
Similarity: 0.98
[ 189442-92-0 ]
1-Boc-4-Formyl-4-methylpiperidine
Similarity: 0.98
[ 873924-08-4 ]
tert-Butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate
Similarity: 0.96
[ 154775-43-6 ]
3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)propanoic acid
Similarity: 0.94
[ 872850-31-2 ]
2-(1-(tert-Butoxycarbonyl)-4-methylpiperidin-4-yl)acetic acid
Similarity: 0.94
[ 137076-22-3 ]
tert-Butyl 4-formylpiperidine-1-carboxylate
Similarity: 0.98
[ 189442-92-0 ]
1-Boc-4-Formyl-4-methylpiperidine
Similarity: 0.98
[ 873924-08-4 ]
tert-Butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate
Similarity: 0.96
[ 154775-43-6 ]
3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)propanoic acid
Similarity: 0.94
[ 872850-31-2 ]
2-(1-(tert-Butoxycarbonyl)-4-methylpiperidin-4-yl)acetic acid
Similarity: 0.94
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :